---
_id: '10301'
abstract:
- lang: eng
  text: De novo protein synthesis is required for synapse modifications underlying
    stable memory encoding. Yet neurons are highly compartmentalized cells and how
    protein synthesis can be regulated at the synapse level is unknown. Here, we characterize
    neuronal signaling complexes formed by the postsynaptic scaffold GIT1, the mechanistic
    target of rapamycin (mTOR) kinase, and Raptor that couple synaptic stimuli to
    mTOR-dependent protein synthesis; and identify NMDA receptors containing GluN3A
    subunits as key negative regulators of GIT1 binding to mTOR. Disruption of GIT1/mTOR
    complexes by enhancing GluN3A expression or silencing GIT1 inhibits synaptic mTOR
    activation and restricts the mTOR-dependent translation of specific activity-regulated
    mRNAs. Conversely, GluN3A removal enables complex formation, potentiates mTOR-dependent
    protein synthesis, and facilitates the consolidation of associative and spatial
    memories in mice. The memory enhancement becomes evident with light or spaced
    training, can be achieved by selectively deleting GluN3A from excitatory neurons
    during adulthood, and does not compromise other aspects of cognition such as memory
    flexibility or extinction. Our findings provide mechanistic insight into synaptic
    translational control and reveal a potentially selective target for cognitive
    enhancement.
acknowledgement: We thank Stuart Lipton and Nobuki Nakanishi for providing the Grin3a
  knockout mice, Beverly Davidson for the AAV-caRheb, Jose Esteban for help with behavioral
  and biochemical experiments, and Noelia Campillo, Rebeca Martínez-Turrillas, and
  Ana Navarro for expert technical help. Work was funded by the UTE project CIMA;
  fellowships from the Fundación Tatiana Pérez de Guzmán el Bueno, FEBS, and IBRO
  (to M.J.C.D.), Generalitat Valenciana (to O.E.-Z.), Juan de la Cierva (to L.G.R.),
  FPI-MINECO (to E.R.V., to S.N.) and Intertalentum postdoctoral program (to V.B.);
  ANR (GluBrain3A) and ERC Advanced Grants (#693021) (to P.P.); Ramón y Cajal program
  RYC2014-15784, RETOS-MINECO SAF2016-76565-R, ERANET-Neuron JTC 2019 ISCIII AC19/00077
  FEDER funds (to R.A.); RETOS-MINECO SAF2017-87928-R (to A.B.); an NIH grant (NS76637)
  and UTHSC College of Medicine funds (to S.J.T.); and NARSAD Independent Investigator
  Award and grants from the MINECO (CSD2008-00005, SAF2013-48983R, SAF2016-80895-R),
  Generalitat Valenciana (PROMETEO 2019/020)(to I.P.O.) and Severo-Ochoa Excellence
  Awards (SEV-2013-0317, SEV-2017-0723).
article_number: e71575
article_processing_charge: No
article_type: original
author:
- first_name: María J
  full_name: Conde-Dusman, María J
  last_name: Conde-Dusman
- first_name: Partha N
  full_name: Dey, Partha N
  last_name: Dey
- first_name: Óscar
  full_name: Elía-Zudaire, Óscar
  last_name: Elía-Zudaire
- first_name: Luis E
  full_name: Garcia Rabaneda, Luis E
  id: 33D1B084-F248-11E8-B48F-1D18A9856A87
  last_name: Garcia Rabaneda
- first_name: Carmen
  full_name: García-Lira, Carmen
  last_name: García-Lira
- first_name: Teddy
  full_name: Grand, Teddy
  last_name: Grand
- first_name: Victor
  full_name: Briz, Victor
  last_name: Briz
- first_name: Eric R
  full_name: Velasco, Eric R
  last_name: Velasco
- first_name: Raül
  full_name: Andero Galí, Raül
  last_name: Andero Galí
- first_name: Sergio
  full_name: Niñerola, Sergio
  last_name: Niñerola
- first_name: Angel
  full_name: Barco, Angel
  last_name: Barco
- first_name: Pierre
  full_name: Paoletti, Pierre
  last_name: Paoletti
- first_name: John F
  full_name: Wesseling, John F
  last_name: Wesseling
- first_name: Fabrizio
  full_name: Gardoni, Fabrizio
  last_name: Gardoni
- first_name: Steven J
  full_name: Tavalin, Steven J
  last_name: Tavalin
- first_name: Isabel
  full_name: Perez-Otaño, Isabel
  last_name: Perez-Otaño
citation:
  ama: Conde-Dusman MJ, Dey PN, Elía-Zudaire Ó, et al. Control of protein synthesis
    and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly.
    <i>eLife</i>. 2021;10. doi:<a href="https://doi.org/10.7554/elife.71575">10.7554/elife.71575</a>
  apa: Conde-Dusman, M. J., Dey, P. N., Elía-Zudaire, Ó., Garcia Rabaneda, L. E.,
    García-Lira, C., Grand, T., … Perez-Otaño, I. (2021). Control of protein synthesis
    and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly.
    <i>ELife</i>. eLife Sciences Publications. <a href="https://doi.org/10.7554/elife.71575">https://doi.org/10.7554/elife.71575</a>
  chicago: Conde-Dusman, María J, Partha N Dey, Óscar Elía-Zudaire, Luis E Garcia
    Rabaneda, Carmen García-Lira, Teddy Grand, Victor Briz, et al. “Control of Protein
    Synthesis and Memory by GluN3A-NMDA Receptors through Inhibition of GIT1/MTORC1
    Assembly.” <i>ELife</i>. eLife Sciences Publications, 2021. <a href="https://doi.org/10.7554/elife.71575">https://doi.org/10.7554/elife.71575</a>.
  ieee: M. J. Conde-Dusman <i>et al.</i>, “Control of protein synthesis and memory
    by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly,” <i>eLife</i>,
    vol. 10. eLife Sciences Publications, 2021.
  ista: Conde-Dusman MJ, Dey PN, Elía-Zudaire Ó, Garcia Rabaneda LE, García-Lira C,
    Grand T, Briz V, Velasco ER, Andero Galí R, Niñerola S, Barco A, Paoletti P, Wesseling
    JF, Gardoni F, Tavalin SJ, Perez-Otaño I. 2021. Control of protein synthesis and
    memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly. eLife.
    10, e71575.
  mla: Conde-Dusman, María J., et al. “Control of Protein Synthesis and Memory by
    GluN3A-NMDA Receptors through Inhibition of GIT1/MTORC1 Assembly.” <i>ELife</i>,
    vol. 10, e71575, eLife Sciences Publications, 2021, doi:<a href="https://doi.org/10.7554/elife.71575">10.7554/elife.71575</a>.
  short: M.J. Conde-Dusman, P.N. Dey, Ó. Elía-Zudaire, L.E. Garcia Rabaneda, C. García-Lira,
    T. Grand, V. Briz, E.R. Velasco, R. Andero Galí, S. Niñerola, A. Barco, P. Paoletti,
    J.F. Wesseling, F. Gardoni, S.J. Tavalin, I. Perez-Otaño, ELife 10 (2021).
date_created: 2021-11-18T06:59:45Z
date_published: 2021-11-17T00:00:00Z
date_updated: 2023-08-14T11:50:50Z
day: '17'
ddc:
- '570'
department:
- _id: GaNo
doi: 10.7554/elife.71575
external_id:
  isi:
  - '000720945900001'
file:
- access_level: open_access
  checksum: 59318e9e41507cec83c2f4070e6ad540
  content_type: application/pdf
  creator: lgarciar
  date_created: 2021-11-18T07:02:02Z
  date_updated: 2021-11-18T07:02:02Z
  file_id: '10302'
  file_name: elife-71575-v1.pdf
  file_size: 2477302
  relation: main_file
  success: 1
file_date_updated: 2021-11-18T07:02:02Z
has_accepted_license: '1'
intvolume: '        10'
isi: 1
keyword:
- general immunology and microbiology
- general biochemistry
- genetics and molecular biology
- general medicine
- general neuroscience
language:
- iso: eng
month: '11'
oa: 1
oa_version: Published Version
publication: eLife
publication_identifier:
  issn:
  - 2050-084X
publication_status: published
publisher: eLife Sciences Publications
quality_controlled: '1'
status: public
title: Control of protein synthesis and memory by GluN3A-NMDA receptors through inhibition
  of GIT1/mTORC1 assembly
tmp:
  image: /images/cc_by.png
  legal_code_url: https://creativecommons.org/licenses/by/4.0/legalcode
  name: Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)
  short: CC BY (4.0)
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 10
year: '2021'
...
---
_id: '9953'
abstract:
- lang: eng
  text: Chronic psychological stress is one of the most important triggers and environmental
    risk factors for neuropsychiatric disorders. Chronic stress can influence all
    organs via the secretion of stress hormones, including glucocorticoids by the
    adrenal glands, which coordinate the stress response across the body. In the brain,
    glucocorticoid receptors (GR) are expressed by various cell types including microglia,
    which are its resident immune cells regulating stress-induced inflammatory processes.
    To study the roles of microglial GR under normal homeostatic conditions and following
    chronic stress, we generated a mouse model in which the GR gene is depleted in
    microglia specifically at adulthood to prevent developmental confounds. We first
    confirmed that microglia were depleted in GR in our model in males and females
    among the cingulate cortex and the hippocampus, both stress-sensitive brain regions.
    Then, cohorts of microglial-GR depleted and wild-type (WT) adult female mice were
    housed for 3 weeks in a standard or stressful condition, using a chronic unpredictable
    mild stress (CUMS) paradigm. CUMS induced stress-related behavior in both microglial-GR
    depleted and WT animals as demonstrated by a decrease of both saccharine preference
    and progressive ratio breakpoint. Nevertheless, the hippocampal microglial and
    neural mechanisms underlying the adaptation to stress occurred differently between
    the two genotypes. Upon CUMS exposure, microglial morphology was altered in the
    WT controls, without any apparent effect in microglial-GR depleted mice. Furthermore,
    in the standard environment condition, GR depleted-microglia showed increased
    expression of pro-inflammatory genes, and genes involved in microglial homeostatic
    functions (such as Trem2, Cx3cr1 and Mertk). On the contrary, in CUMS condition,
    GR depleted-microglia showed reduced expression levels of pro-inflammatory genes
    and increased neuroprotective as well as anti-inflammatory genes compared to WT-microglia.
    Moreover, in microglial-GR depleted mice, but not in WT mice, CUMS led to a significant
    reduction of CA1 long-term potentiation and paired-pulse ratio. Lastly, differences
    in adult hippocampal neurogenesis were observed between the genotypes during normal
    homeostatic conditions, with microglial-GR deficiency increasing the formation
    of newborn neurons in the dentate gyrus subgranular zone independently from stress
    exposure. Together, these findings indicate that, although the deletion of microglial
    GR did not prevent the animal’s ability to respond to stress, it contributed to
    modulating hippocampal functions in both standard and stressful conditions, notably
    by shaping the microglial response to chronic stress.
acknowledgement: We acknowledge that Université Laval stands on the traditional and
  unceded land of the Huron-Wendat peoples; and that the University of Victoria exists
  on the territory of the Lekwungen peoples and that the Songhees, Esquimalt and WSÁNEÆ
  peoples have relationships to this land. We thank Emmanuel Planel for the access
  to the epifluorescence microscope and Julie-Christine Lévesque at the Bioimaging
  Platform of CRCHU de Québec-Université Laval for technical assistance. We also thank
  the Centre for Advanced Materials and Related Technology for the access to the confocal
  microscope with Airyscan. K.P. was supported by a doctoral scholarship from Fonds
  de Recherche du Québec – Santé (FRQS), an excellence award from Fondation du CHU
  de Québec, as well as from Centre Thématique de Recherche en Neurosciences and from
  Fondation Famille-Choquette. K.B. was supported by excellence scholarships from
  Université Laval and Fondation du CHU de Québec. S.G. is supported by FIRC-AIRC
  fellowship for Italy 22329/2018 and by Pilot ARISLA NKINALS 2019. C.W.H. and J.C.S.
  were supported by postdoctoral fellowships from FRQS. This study was funded by a
  Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant
  (RGPIN-2014-05308) awarded to M.E.T., by ERANET neuron 2017 MicroSynDep to M.E.T.
  and I.B., and by the Italian Ministry of Health, grant RF-2018-12367249 to I.B,
  by PRIN 2017, AIRC 2019 and Ministero della Salute RF2018 to C.L. M.E.T. is a Tier
  II Canada Research Chair in Neurobiology of Aging and Cognition.
article_processing_charge: No
article_type: original
author:
- first_name: Katherine
  full_name: Picard, Katherine
  last_name: Picard
- first_name: Kanchan
  full_name: Bisht, Kanchan
  last_name: Bisht
- first_name: Silvia
  full_name: Poggini, Silvia
  last_name: Poggini
- first_name: Stefano
  full_name: Garofalo, Stefano
  last_name: Garofalo
- first_name: Maria Teresa
  full_name: Golia, Maria Teresa
  last_name: Golia
- first_name: Bernadette
  full_name: Basilico, Bernadette
  id: 36035796-5ACA-11E9-A75E-7AF2E5697425
  last_name: Basilico
  orcid: 0000-0003-1843-3173
- first_name: Fatima
  full_name: Abdallah, Fatima
  last_name: Abdallah
- first_name: Naomi
  full_name: Ciano Albanese, Naomi
  last_name: Ciano Albanese
- first_name: Irmgard
  full_name: Amrein, Irmgard
  last_name: Amrein
- first_name: Nathalie
  full_name: Vernoux, Nathalie
  last_name: Vernoux
- first_name: Kaushik
  full_name: Sharma, Kaushik
  last_name: Sharma
- first_name: Chin Wai
  full_name: Hui, Chin Wai
  last_name: Hui
- first_name: Julie
  full_name: C. Savage, Julie
  last_name: C. Savage
- first_name: Cristina
  full_name: Limatola, Cristina
  last_name: Limatola
- first_name: Davide
  full_name: Ragozzino, Davide
  last_name: Ragozzino
- first_name: Laura
  full_name: Maggi, Laura
  last_name: Maggi
- first_name: Igor
  full_name: Branchi, Igor
  last_name: Branchi
- first_name: Marie Ève
  full_name: Tremblay, Marie Ève
  last_name: Tremblay
citation:
  ama: Picard K, Bisht K, Poggini S, et al. Microglial-glucocorticoid receptor depletion
    alters the response of hippocampal microglia and neurons in a chronic unpredictable
    mild stress paradigm in female mice. <i>Brain, Behavior, and Immunity</i>. 2021;97:423-439.
    doi:<a href="https://doi.org/10.1016/j.bbi.2021.07.022">10.1016/j.bbi.2021.07.022</a>
  apa: Picard, K., Bisht, K., Poggini, S., Garofalo, S., Golia, M. T., Basilico, B.,
    … Tremblay, M. È. (2021). Microglial-glucocorticoid receptor depletion alters
    the response of hippocampal microglia and neurons in a chronic unpredictable mild
    stress paradigm in female mice. <i>Brain, Behavior, and Immunity</i>. Elsevier.
    <a href="https://doi.org/10.1016/j.bbi.2021.07.022">https://doi.org/10.1016/j.bbi.2021.07.022</a>
  chicago: Picard, Katherine, Kanchan Bisht, Silvia Poggini, Stefano Garofalo, Maria
    Teresa Golia, Bernadette Basilico, Fatima Abdallah, et al. “Microglial-Glucocorticoid
    Receptor Depletion Alters the Response of Hippocampal Microglia and Neurons in
    a Chronic Unpredictable Mild Stress Paradigm in Female Mice.” <i>Brain, Behavior,
    and Immunity</i>. Elsevier, 2021. <a href="https://doi.org/10.1016/j.bbi.2021.07.022">https://doi.org/10.1016/j.bbi.2021.07.022</a>.
  ieee: K. Picard <i>et al.</i>, “Microglial-glucocorticoid receptor depletion alters
    the response of hippocampal microglia and neurons in a chronic unpredictable mild
    stress paradigm in female mice,” <i>Brain, Behavior, and Immunity</i>, vol. 97.
    Elsevier, pp. 423–439, 2021.
  ista: Picard K, Bisht K, Poggini S, Garofalo S, Golia MT, Basilico B, Abdallah F,
    Ciano Albanese N, Amrein I, Vernoux N, Sharma K, Hui CW, C. Savage J, Limatola
    C, Ragozzino D, Maggi L, Branchi I, Tremblay MÈ. 2021. Microglial-glucocorticoid
    receptor depletion alters the response of hippocampal microglia and neurons in
    a chronic unpredictable mild stress paradigm in female mice. Brain, Behavior,
    and Immunity. 97, 423–439.
  mla: Picard, Katherine, et al. “Microglial-Glucocorticoid Receptor Depletion Alters
    the Response of Hippocampal Microglia and Neurons in a Chronic Unpredictable Mild
    Stress Paradigm in Female Mice.” <i>Brain, Behavior, and Immunity</i>, vol. 97,
    Elsevier, 2021, pp. 423–39, doi:<a href="https://doi.org/10.1016/j.bbi.2021.07.022">10.1016/j.bbi.2021.07.022</a>.
  short: K. Picard, K. Bisht, S. Poggini, S. Garofalo, M.T. Golia, B. Basilico, F.
    Abdallah, N. Ciano Albanese, I. Amrein, N. Vernoux, K. Sharma, C.W. Hui, J. C.
    Savage, C. Limatola, D. Ragozzino, L. Maggi, I. Branchi, M.È. Tremblay, Brain,
    Behavior, and Immunity 97 (2021) 423–439.
date_created: 2021-08-22T22:01:21Z
date_published: 2021-10-01T00:00:00Z
date_updated: 2023-10-03T09:49:18Z
day: '01'
department:
- _id: GaNo
doi: 10.1016/j.bbi.2021.07.022
external_id:
  isi:
  - '000702878400007'
  pmid:
  - '34343616'
intvolume: '        97'
isi: 1
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://www.zora.uzh.ch/id/eprint/208855/1/ZORA208855.pdf
month: '10'
oa: 1
oa_version: Submitted Version
page: 423-439
pmid: 1
publication: Brain, Behavior, and Immunity
publication_identifier:
  issn:
  - 0889-1591
publication_status: published
publisher: Elsevier
quality_controlled: '1'
scopus_import: '1'
status: public
title: Microglial-glucocorticoid receptor depletion alters the response of hippocampal
  microglia and neurons in a chronic unpredictable mild stress paradigm in female
  mice
type: journal_article
user_id: 2DF688A6-F248-11E8-B48F-1D18A9856A87
volume: 97
year: '2021'
...
---
_id: '7800'
abstract:
- lang: eng
  text: De novo loss of function mutations in the ubiquitin ligase-encoding gene Cullin3
    (CUL3) lead to autism spectrum disorder (ASD). Here, we used Cul3 mouse models
    to evaluate the consequences of Cul3 mutations in vivo. Our results show that
    Cul3 haploinsufficient mice exhibit deficits in motor coordination as well as
    ASD-relevant social and cognitive impairments. Cul3 mutant brain displays cortical
    lamination abnormalities due to defective neuronal migration and reduced numbers
    of excitatory and inhibitory neurons. In line with the observed abnormal columnar
    organization, Cul3 haploinsufficiency is associated with decreased spontaneous
    excitatory and inhibitory activity in the cortex. At the molecular level, employing
    a quantitative proteomic approach, we show that Cul3 regulates cytoskeletal and
    adhesion protein abundance in mouse embryos. Abnormal regulation of cytoskeletal
    proteins in Cul3 mutant neuronal cells results in atypical organization of the
    actin mesh at the cell leading edge, likely causing the observed migration deficits.
    In contrast to these important functions early in development, Cul3 deficiency
    appears less relevant at adult stages. In fact, induction of Cul3 haploinsufficiency
    in adult mice does not result in the behavioral defects observed in constitutive
    Cul3 haploinsufficient animals. Taken together, our data indicate that Cul3 has
    a critical role in the regulation of cytoskeletal proteins and neuronal migration
    and that ASD-associated defects and behavioral abnormalities are primarily due
    to Cul3 functions at early developmental stages.
acknowledged_ssus:
- _id: PreCl
article_processing_charge: No
author:
- first_name: Jasmin
  full_name: Morandell, Jasmin
  id: 4739D480-F248-11E8-B48F-1D18A9856A87
  last_name: Morandell
- first_name: Lena A
  full_name: Schwarz, Lena A
  id: 29A8453C-F248-11E8-B48F-1D18A9856A87
  last_name: Schwarz
- first_name: Bernadette
  full_name: Basilico, Bernadette
  id: 36035796-5ACA-11E9-A75E-7AF2E5697425
  last_name: Basilico
  orcid: 0000-0003-1843-3173
- first_name: Saren
  full_name: Tasciyan, Saren
  id: 4323B49C-F248-11E8-B48F-1D18A9856A87
  last_name: Tasciyan
  orcid: 0000-0003-1671-393X
- first_name: Armel
  full_name: Nicolas, Armel
  id: 2A103192-F248-11E8-B48F-1D18A9856A87
  last_name: Nicolas
- first_name: Christoph M
  full_name: Sommer, Christoph M
  id: 4DF26D8C-F248-11E8-B48F-1D18A9856A87
  last_name: Sommer
  orcid: 0000-0003-1216-9105
- first_name: Caroline
  full_name: Kreuzinger, Caroline
  id: 382077BA-F248-11E8-B48F-1D18A9856A87
  last_name: Kreuzinger
- first_name: Lisa
  full_name: Knaus, Lisa
  id: 3B2ABCF4-F248-11E8-B48F-1D18A9856A87
  last_name: Knaus
- first_name: Zoe
  full_name: Dobler, Zoe
  id: D23090A2-9057-11EA-883A-A8396FC7A38F
  last_name: Dobler
- first_name: Emanuele
  full_name: Cacci, Emanuele
  last_name: Cacci
- first_name: Johann G
  full_name: Danzl, Johann G
  id: 42EFD3B6-F248-11E8-B48F-1D18A9856A87
  last_name: Danzl
  orcid: 0000-0001-8559-3973
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: Morandell J, Schwarz LA, Basilico B, et al. Cul3 regulates cytoskeleton protein
    homeostasis and cell migration during a critical window of brain development.
    <i>bioRxiv</i>. doi:<a href="https://doi.org/10.1101/2020.01.10.902064 ">10.1101/2020.01.10.902064
    </a>
  apa: Morandell, J., Schwarz, L. A., Basilico, B., Tasciyan, S., Nicolas, A., Sommer,
    C. M., … Novarino, G. (n.d.). Cul3 regulates cytoskeleton protein homeostasis
    and cell migration during a critical window of brain development. <i>bioRxiv</i>.
    Cold Spring Harbor Laboratory. <a href="https://doi.org/10.1101/2020.01.10.902064
    ">https://doi.org/10.1101/2020.01.10.902064 </a>
  chicago: Morandell, Jasmin, Lena A Schwarz, Bernadette Basilico, Saren Tasciyan,
    Armel Nicolas, Christoph M Sommer, Caroline Kreuzinger, et al. “Cul3 Regulates
    Cytoskeleton Protein Homeostasis and Cell Migration during a Critical Window of
    Brain Development.” <i>BioRxiv</i>. Cold Spring Harbor Laboratory, n.d. <a href="https://doi.org/10.1101/2020.01.10.902064
    ">https://doi.org/10.1101/2020.01.10.902064 </a>.
  ieee: J. Morandell <i>et al.</i>, “Cul3 regulates cytoskeleton protein homeostasis
    and cell migration during a critical window of brain development,” <i>bioRxiv</i>.
    Cold Spring Harbor Laboratory.
  ista: Morandell J, Schwarz LA, Basilico B, Tasciyan S, Nicolas A, Sommer CM, Kreuzinger
    C, Knaus L, Dobler Z, Cacci E, Danzl JG, Novarino G. Cul3 regulates cytoskeleton
    protein homeostasis and cell migration during a critical window of brain development.
    bioRxiv, <a href="https://doi.org/10.1101/2020.01.10.902064 ">10.1101/2020.01.10.902064
    </a>.
  mla: Morandell, Jasmin, et al. “Cul3 Regulates Cytoskeleton Protein Homeostasis
    and Cell Migration during a Critical Window of Brain Development.” <i>BioRxiv</i>,
    Cold Spring Harbor Laboratory, doi:<a href="https://doi.org/10.1101/2020.01.10.902064
    ">10.1101/2020.01.10.902064 </a>.
  short: J. Morandell, L.A. Schwarz, B. Basilico, S. Tasciyan, A. Nicolas, C.M. Sommer,
    C. Kreuzinger, L. Knaus, Z. Dobler, E. Cacci, J.G. Danzl, G. Novarino, BioRxiv
    (n.d.).
date_created: 2020-05-05T14:31:33Z
date_published: 2020-01-11T00:00:00Z
date_updated: 2024-09-10T12:04:26Z
day: '11'
ddc:
- '570'
department:
- _id: JoDa
- _id: GaNo
- _id: LifeSc
doi: '10.1101/2020.01.10.902064 '
file:
- access_level: open_access
  checksum: c6799ab5daba80efe8e2ed63c15f8c81
  content_type: application/pdf
  creator: rsix
  date_created: 2020-05-05T14:31:19Z
  date_updated: 2020-07-14T12:48:03Z
  file_id: '7801'
  file_name: 2020.01.10.902064v1.full.pdf
  file_size: 2931370
  relation: main_file
file_date_updated: 2020-07-14T12:48:03Z
has_accepted_license: '1'
language:
- iso: eng
month: '01'
oa: 1
oa_version: Preprint
project:
- _id: 265CB4D0-B435-11E9-9278-68D0E5697425
  call_identifier: FWF
  grant_number: I03600
  name: Optical control of synaptic function via adhesion molecules
- _id: 2548AE96-B435-11E9-9278-68D0E5697425
  call_identifier: FWF
  grant_number: W1232-B24
  name: Molecular Drug Targets
publication: bioRxiv
publication_status: submitted
publisher: Cold Spring Harbor Laboratory
related_material:
  record:
  - id: '8620'
    relation: dissertation_contains
    status: public
  - id: '9429'
    relation: later_version
    status: public
status: public
title: Cul3 regulates cytoskeleton protein homeostasis and cell migration during a
  critical window of brain development
tmp:
  image: /images/cc_by_nc_nd.png
  legal_code_url: https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode
  name: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
    (CC BY-NC-ND 4.0)
  short: CC BY-NC-ND (4.0)
type: preprint
user_id: 2DF688A6-F248-11E8-B48F-1D18A9856A87
year: '2020'
...
---
_id: '7877'
abstract:
- lang: eng
  text: The NIPBL/MAU2 heterodimer loads cohesin onto chromatin. Mutations inNIPBLaccount
    for most cases ofthe rare developmental disorder Cornelia de Lange syndrome (CdLS).
    Here we report aMAU2 variant causing CdLS, a deletion of seven amino acids that
    impairs the interaction between MAU2 and the NIPBL N terminus.Investigating this
    interaction, we discovered that MAU2 and the NIPBL N terminus are largely dispensable
    fornormal cohesin and NIPBL function in cells with a NIPBL early truncating mutation.
    Despite a predicted fataloutcome of an out-of-frame single nucleotide duplication
    inNIPBL, engineered in two different cell lines,alternative translation initiation
    yields a form of NIPBL missing N-terminal residues. This form cannot interactwith
    MAU2, but binds DNA and mediates cohesin loading. Altogether, our work reveals
    that cohesin loading can occur independently of functional NIPBL/MAU2 complexes
    and highlights a novel mechanism protectiveagainst out-of-frame mutations that
    is potentially relevant for other genetic conditions.
article_number: '107647'
article_processing_charge: No
article_type: original
author:
- first_name: Ilaria
  full_name: Parenti, Ilaria
  id: D93538B0-5B71-11E9-AC62-02EBE5697425
  last_name: Parenti
- first_name: Farah
  full_name: Diab, Farah
  last_name: Diab
- first_name: Sara Ruiz
  full_name: Gil, Sara Ruiz
  last_name: Gil
- first_name: Eskeatnaf
  full_name: Mulugeta, Eskeatnaf
  last_name: Mulugeta
- first_name: Valentina
  full_name: Casa, Valentina
  last_name: Casa
- first_name: Riccardo
  full_name: Berutti, Riccardo
  last_name: Berutti
- first_name: Rutger W.W.
  full_name: Brouwer, Rutger W.W.
  last_name: Brouwer
- first_name: Valerie
  full_name: Dupé, Valerie
  last_name: Dupé
- first_name: Juliane
  full_name: Eckhold, Juliane
  last_name: Eckhold
- first_name: Elisabeth
  full_name: Graf, Elisabeth
  last_name: Graf
- first_name: Beatriz
  full_name: Puisac, Beatriz
  last_name: Puisac
- first_name: Feliciano
  full_name: Ramos, Feliciano
  last_name: Ramos
- first_name: Thomas
  full_name: Schwarzmayr, Thomas
  last_name: Schwarzmayr
- first_name: Macarena Moronta
  full_name: Gines, Macarena Moronta
  last_name: Gines
- first_name: Thomas
  full_name: Van Staveren, Thomas
  last_name: Van Staveren
- first_name: Wilfred F.J.
  full_name: Van Ijcken, Wilfred F.J.
  last_name: Van Ijcken
- first_name: Tim M.
  full_name: Strom, Tim M.
  last_name: Strom
- first_name: Juan
  full_name: Pié, Juan
  last_name: Pié
- first_name: Erwan
  full_name: Watrin, Erwan
  last_name: Watrin
- first_name: Frank J.
  full_name: Kaiser, Frank J.
  last_name: Kaiser
- first_name: Kerstin S.
  full_name: Wendt, Kerstin S.
  last_name: Wendt
citation:
  ama: Parenti I, Diab F, Gil SR, et al. MAU2 and NIPBL variants impair the heterodimerization
    of the cohesin loader subunits and cause Cornelia de Lange syndrome. <i>Cell Reports</i>.
    2020;31(7). doi:<a href="https://doi.org/10.1016/j.celrep.2020.107647">10.1016/j.celrep.2020.107647</a>
  apa: Parenti, I., Diab, F., Gil, S. R., Mulugeta, E., Casa, V., Berutti, R., … Wendt,
    K. S. (2020). MAU2 and NIPBL variants impair the heterodimerization of the cohesin
    loader subunits and cause Cornelia de Lange syndrome. <i>Cell Reports</i>. Elsevier.
    <a href="https://doi.org/10.1016/j.celrep.2020.107647">https://doi.org/10.1016/j.celrep.2020.107647</a>
  chicago: Parenti, Ilaria, Farah Diab, Sara Ruiz Gil, Eskeatnaf Mulugeta, Valentina
    Casa, Riccardo Berutti, Rutger W.W. Brouwer, et al. “MAU2 and NIPBL Variants Impair
    the Heterodimerization of the Cohesin Loader Subunits and Cause Cornelia de Lange
    Syndrome.” <i>Cell Reports</i>. Elsevier, 2020. <a href="https://doi.org/10.1016/j.celrep.2020.107647">https://doi.org/10.1016/j.celrep.2020.107647</a>.
  ieee: I. Parenti <i>et al.</i>, “MAU2 and NIPBL variants impair the heterodimerization
    of the cohesin loader subunits and cause Cornelia de Lange syndrome,” <i>Cell
    Reports</i>, vol. 31, no. 7. Elsevier, 2020.
  ista: Parenti I, Diab F, Gil SR, Mulugeta E, Casa V, Berutti R, Brouwer RWW, Dupé
    V, Eckhold J, Graf E, Puisac B, Ramos F, Schwarzmayr T, Gines MM, Van Staveren
    T, Van Ijcken WFJ, Strom TM, Pié J, Watrin E, Kaiser FJ, Wendt KS. 2020. MAU2
    and NIPBL variants impair the heterodimerization of the cohesin loader subunits
    and cause Cornelia de Lange syndrome. Cell Reports. 31(7), 107647.
  mla: Parenti, Ilaria, et al. “MAU2 and NIPBL Variants Impair the Heterodimerization
    of the Cohesin Loader Subunits and Cause Cornelia de Lange Syndrome.” <i>Cell
    Reports</i>, vol. 31, no. 7, 107647, Elsevier, 2020, doi:<a href="https://doi.org/10.1016/j.celrep.2020.107647">10.1016/j.celrep.2020.107647</a>.
  short: I. Parenti, F. Diab, S.R. Gil, E. Mulugeta, V. Casa, R. Berutti, R.W.W. Brouwer,
    V. Dupé, J. Eckhold, E. Graf, B. Puisac, F. Ramos, T. Schwarzmayr, M.M. Gines,
    T. Van Staveren, W.F.J. Van Ijcken, T.M. Strom, J. Pié, E. Watrin, F.J. Kaiser,
    K.S. Wendt, Cell Reports 31 (2020).
date_created: 2020-05-24T22:00:57Z
date_published: 2020-05-19T00:00:00Z
date_updated: 2023-08-21T06:27:47Z
day: '19'
ddc:
- '570'
department:
- _id: GaNo
doi: 10.1016/j.celrep.2020.107647
external_id:
  isi:
  - '000535655200005'
file:
- access_level: open_access
  checksum: 64d8f7467731ee5c166b10b939b8310b
  content_type: application/pdf
  creator: dernst
  date_created: 2020-05-26T11:05:01Z
  date_updated: 2020-07-14T12:48:04Z
  file_id: '7892'
  file_name: 2020_CellReports_Parenti.pdf
  file_size: 4695682
  relation: main_file
file_date_updated: 2020-07-14T12:48:04Z
has_accepted_license: '1'
intvolume: '        31'
isi: 1
issue: '7'
language:
- iso: eng
month: '05'
oa: 1
oa_version: Published Version
publication: Cell Reports
publication_identifier:
  eissn:
  - '22111247'
publication_status: published
publisher: Elsevier
quality_controlled: '1'
scopus_import: '1'
status: public
title: MAU2 and NIPBL variants impair the heterodimerization of the cohesin loader
  subunits and cause Cornelia de Lange syndrome
tmp:
  image: /images/cc_by_nc_nd.png
  legal_code_url: https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode
  name: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
    (CC BY-NC-ND 4.0)
  short: CC BY-NC-ND (4.0)
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 31
year: '2020'
...
---
_id: '7957'
abstract:
- lang: eng
  text: "Neurodevelopmental disorders (NDDs) are a class of disorders affecting brain
    development and function and are characterized by wide genetic and clinical variability.
    In this review, we discuss the multiple factors that influence the clinical presentation
    of NDDs, with particular attention to gene vulnerability, mutational load, and
    the two-hit model. Despite the complex architecture of\r\nmutational events associated
    with NDDs, the various proteins involved appear to converge on common pathways,
    such as synaptic plasticity/function, chromatin remodelers and the mammalian target
    of rapamycin (mTOR) pathway. A thorough understanding of the mechanisms behind
    these pathways will hopefully lead to the identification of candidates that could
    be targeted for treatment approaches."
acknowledgement: We wish to thank Jasmin Morandell for generously sharing Figure 2.
  This work was supported by the European Research Council Starting Grant (grant 715508
  ) to G.N.
article_processing_charge: No
article_type: original
author:
- first_name: Ilaria
  full_name: Parenti, Ilaria
  id: D93538B0-5B71-11E9-AC62-02EBE5697425
  last_name: Parenti
- first_name: Luis E
  full_name: Garcia Rabaneda, Luis E
  id: 33D1B084-F248-11E8-B48F-1D18A9856A87
  last_name: Garcia Rabaneda
- first_name: Hanna
  full_name: Schön, Hanna
  id: C8E17EDC-D7AA-11E9-B7B7-45ECE5697425
  last_name: Schön
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: 'Parenti I, Garcia Rabaneda LE, Schön H, Novarino G. Neurodevelopmental disorders:
    From genetics to functional pathways. <i>Trends in Neurosciences</i>. 2020;43(8):608-621.
    doi:<a href="https://doi.org/10.1016/j.tins.2020.05.004">10.1016/j.tins.2020.05.004</a>'
  apa: 'Parenti, I., Garcia Rabaneda, L. E., Schön, H., &#38; Novarino, G. (2020).
    Neurodevelopmental disorders: From genetics to functional pathways. <i>Trends
    in Neurosciences</i>. Elsevier. <a href="https://doi.org/10.1016/j.tins.2020.05.004">https://doi.org/10.1016/j.tins.2020.05.004</a>'
  chicago: 'Parenti, Ilaria, Luis E Garcia Rabaneda, Hanna Schön, and Gaia Novarino.
    “Neurodevelopmental Disorders: From Genetics to Functional Pathways.” <i>Trends
    in Neurosciences</i>. Elsevier, 2020. <a href="https://doi.org/10.1016/j.tins.2020.05.004">https://doi.org/10.1016/j.tins.2020.05.004</a>.'
  ieee: 'I. Parenti, L. E. Garcia Rabaneda, H. Schön, and G. Novarino, “Neurodevelopmental
    disorders: From genetics to functional pathways,” <i>Trends in Neurosciences</i>,
    vol. 43, no. 8. Elsevier, pp. 608–621, 2020.'
  ista: 'Parenti I, Garcia Rabaneda LE, Schön H, Novarino G. 2020. Neurodevelopmental
    disorders: From genetics to functional pathways. Trends in Neurosciences. 43(8),
    608–621.'
  mla: 'Parenti, Ilaria, et al. “Neurodevelopmental Disorders: From Genetics to Functional
    Pathways.” <i>Trends in Neurosciences</i>, vol. 43, no. 8, Elsevier, 2020, pp.
    608–21, doi:<a href="https://doi.org/10.1016/j.tins.2020.05.004">10.1016/j.tins.2020.05.004</a>.'
  short: I. Parenti, L.E. Garcia Rabaneda, H. Schön, G. Novarino, Trends in Neurosciences
    43 (2020) 608–621.
date_created: 2020-06-14T22:00:49Z
date_published: 2020-08-01T00:00:00Z
date_updated: 2023-08-21T08:25:31Z
day: '01'
ddc:
- '570'
department:
- _id: GaNo
doi: 10.1016/j.tins.2020.05.004
ec_funded: 1
external_id:
  isi:
  - '000553090600008'
  pmid:
  - '32507511'
file:
- access_level: open_access
  checksum: 67db0251b1d415ae59005f876fcf9e34
  content_type: application/pdf
  creator: dernst
  date_created: 2020-11-25T09:43:40Z
  date_updated: 2020-11-25T09:43:40Z
  file_id: '8805'
  file_name: 2020_TrendsNeuroscience_Parenti.pdf
  file_size: 1439550
  relation: main_file
  success: 1
file_date_updated: 2020-11-25T09:43:40Z
has_accepted_license: '1'
intvolume: '        43'
isi: 1
issue: '8'
language:
- iso: eng
month: '08'
oa: 1
oa_version: Published Version
page: 608-621
pmid: 1
project:
- _id: 25444568-B435-11E9-9278-68D0E5697425
  call_identifier: H2020
  grant_number: '715508'
  name: Probing the Reversibility of Autism Spectrum Disorders by Employing in vivo
    and in vitro Models
publication: Trends in Neurosciences
publication_identifier:
  eissn:
  - 1878108X
  issn:
  - '01662236'
publication_status: published
publisher: Elsevier
quality_controlled: '1'
scopus_import: '1'
status: public
title: 'Neurodevelopmental disorders: From genetics to functional pathways'
tmp:
  image: /images/cc_by.png
  legal_code_url: https://creativecommons.org/licenses/by/4.0/legalcode
  name: Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)
  short: CC BY (4.0)
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 43
year: '2020'
...
---
_id: '8131'
abstract:
- lang: eng
  text: The possibility to generate construct valid animal models enabled the development
    and testing of therapeutic strategies targeting the core features of autism spectrum
    disorders (ASDs). At the same time, these studies highlighted the necessity of
    identifying sensitive developmental time windows for successful therapeutic interventions.
    Animal and human studies also uncovered the possibility to stratify the variety
    of ASDs in molecularly distinct subgroups, potentially facilitating effective
    treatment design. Here, we focus on the molecular pathways emerging as commonly
    affected by mutations in diverse ASD-risk genes, on their role during critical
    windows of brain development and the potential treatments targeting these biological
    processes.
article_processing_charge: Yes (via OA deal)
article_type: original
author:
- first_name: Bernadette
  full_name: Basilico, Bernadette
  id: 36035796-5ACA-11E9-A75E-7AF2E5697425
  last_name: Basilico
  orcid: 0000-0003-1843-3173
- first_name: Jasmin
  full_name: Morandell, Jasmin
  id: 4739D480-F248-11E8-B48F-1D18A9856A87
  last_name: Morandell
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: Basilico B, Morandell J, Novarino G. Molecular mechanisms for targeted ASD
    treatments. <i>Current Opinion in Genetics and Development</i>. 2020;65(12):126-137.
    doi:<a href="https://doi.org/10.1016/j.gde.2020.06.004">10.1016/j.gde.2020.06.004</a>
  apa: Basilico, B., Morandell, J., &#38; Novarino, G. (2020). Molecular mechanisms
    for targeted ASD treatments. <i>Current Opinion in Genetics and Development</i>.
    Elsevier. <a href="https://doi.org/10.1016/j.gde.2020.06.004">https://doi.org/10.1016/j.gde.2020.06.004</a>
  chicago: Basilico, Bernadette, Jasmin Morandell, and Gaia Novarino. “Molecular Mechanisms
    for Targeted ASD Treatments.” <i>Current Opinion in Genetics and Development</i>.
    Elsevier, 2020. <a href="https://doi.org/10.1016/j.gde.2020.06.004">https://doi.org/10.1016/j.gde.2020.06.004</a>.
  ieee: B. Basilico, J. Morandell, and G. Novarino, “Molecular mechanisms for targeted
    ASD treatments,” <i>Current Opinion in Genetics and Development</i>, vol. 65,
    no. 12. Elsevier, pp. 126–137, 2020.
  ista: Basilico B, Morandell J, Novarino G. 2020. Molecular mechanisms for targeted
    ASD treatments. Current Opinion in Genetics and Development. 65(12), 126–137.
  mla: Basilico, Bernadette, et al. “Molecular Mechanisms for Targeted ASD Treatments.”
    <i>Current Opinion in Genetics and Development</i>, vol. 65, no. 12, Elsevier,
    2020, pp. 126–37, doi:<a href="https://doi.org/10.1016/j.gde.2020.06.004">10.1016/j.gde.2020.06.004</a>.
  short: B. Basilico, J. Morandell, G. Novarino, Current Opinion in Genetics and Development
    65 (2020) 126–137.
date_created: 2020-07-19T22:00:58Z
date_published: 2020-12-01T00:00:00Z
date_updated: 2024-09-10T12:04:25Z
day: '01'
ddc:
- '570'
department:
- _id: GaNo
doi: 10.1016/j.gde.2020.06.004
ec_funded: 1
external_id:
  isi:
  - '000598918900019'
  pmid:
  - '32659636'
file:
- access_level: open_access
  content_type: application/pdf
  creator: dernst
  date_created: 2020-07-22T06:47:45Z
  date_updated: 2020-07-22T06:47:45Z
  file_id: '8146'
  file_name: 2020_CurrentOpGenetics_Basilico.pdf
  file_size: 1381545
  relation: main_file
  success: 1
file_date_updated: 2020-07-22T06:47:45Z
has_accepted_license: '1'
intvolume: '        65'
isi: 1
issue: '12'
language:
- iso: eng
month: '12'
oa: 1
oa_version: Published Version
page: 126-137
pmid: 1
project:
- _id: 260C2330-B435-11E9-9278-68D0E5697425
  call_identifier: H2020
  grant_number: '754411'
  name: ISTplus - Postdoctoral Fellowships
- _id: 2548AE96-B435-11E9-9278-68D0E5697425
  call_identifier: FWF
  grant_number: W1232-B24
  name: Molecular Drug Targets
- _id: 05A0D778-7A3F-11EA-A408-12923DDC885E
  grant_number: F07807
  name: Neural stem cells in autism and epilepsy
publication: Current Opinion in Genetics and Development
publication_identifier:
  eissn:
  - '18790380'
  issn:
  - 0959437X
publication_status: published
publisher: Elsevier
quality_controlled: '1'
related_material:
  record:
  - id: '8620'
    relation: dissertation_contains
    status: public
scopus_import: '1'
status: public
title: Molecular mechanisms for targeted ASD treatments
tmp:
  image: /images/cc_by_nc_nd.png
  legal_code_url: https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode
  name: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
    (CC BY-NC-ND 4.0)
  short: CC BY-NC-ND (4.0)
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 65
year: '2020'
...
---
_id: '8620'
abstract:
- lang: eng
  text: "The development of the human brain occurs through a tightly regulated series
    of dynamic and adaptive processes during prenatal and postnatal life. A disruption
    of this strictly orchestrated series of events can lead to a number of neurodevelopmental
    conditions, including Autism Spectrum Disorders (ASDs). ASDs are a very common,
    etiologically and phenotypically heterogeneous group of disorders sharing the
    core symptoms of social interaction and communication deficits and restrictive
    and repetitive interests and behaviors. They are estimated to affect one in 59
    individuals in the U.S. and, over the last three decades, mutations in more than
    a hundred genetic loci have been convincingly linked to ASD pathogenesis. Yet,
    for the vast majority of these ASD-risk genes their role during brain development
    and precise molecular function still remain elusive.\r\nDe novo loss of function
    mutations in the ubiquitin ligase-encoding gene Cullin 3 (CUL3) lead to ASD. In
    the study described here, we used Cul3 mouse models to evaluate the consequences
    of Cul3 mutations in vivo. Our results show that Cul3 heterozygous knockout mice
    exhibit deficits in motor coordination as well as ASD-relevant social and cognitive
    impairments. Cul3+/-, Cul3+/fl Emx1-Cre and Cul3fl/fl Emx1-Cre mutant brains display
    cortical lamination abnormalities due to defective migration of post-mitotic excitatory
    neurons, as well as reduced numbers of excitatory and inhibitory neurons. In line
    with the observed abnormal cortical organization, Cul3 heterozygous deletion is
    associated with decreased spontaneous excitatory and inhibitory activity in the
    cortex. At the molecular level we show that Cul3 regulates cytoskeletal and adhesion
    protein abundance in the mouse embryonic cortex. Abnormal regulation of cytoskeletal
    proteins in Cul3 mutant neural cells results in atypical organization of the actin
    mesh at the cell leading edge. Of note, heterozygous deletion of Cul3 in adult
    mice does not induce the majority of the behavioral defects observed in constitutive
    Cul3 haploinsufficient animals, pointing to a critical time-window for Cul3 deficiency.\r\nIn
    conclusion, our data indicate that Cul3 plays a critical role in the regulation
    of cytoskeletal proteins and neuronal migration. ASD-associated defects and behavioral
    abnormalities are primarily due to dosage sensitive Cul3 functions at early brain
    developmental stages."
acknowledged_ssus:
- _id: Bio
- _id: PreCl
acknowledgement: I would like to especially thank Armel Nicolas from the Proteomics
  and Christoph Sommer from the Bioimaging Facilities for the data analysis, and to
  thank the team of the Preclinical Facility, especially Sabina Deixler, Angela Schlerka,
  Anita Lepold, Mihalea Mihai and Michael Schun for taking care of the mouse line
  maintenance and their great support.
alternative_title:
- ISTA Thesis
article_processing_charge: No
author:
- first_name: Jasmin
  full_name: Morandell, Jasmin
  id: 4739D480-F248-11E8-B48F-1D18A9856A87
  last_name: Morandell
citation:
  ama: Morandell J. Illuminating the role of Cul3 in autism spectrum disorder pathogenesis.
    2020. doi:<a href="https://doi.org/10.15479/AT:ISTA:8620">10.15479/AT:ISTA:8620</a>
  apa: Morandell, J. (2020). <i>Illuminating the role of Cul3 in autism spectrum disorder
    pathogenesis</i>. Institute of Science and Technology Austria. <a href="https://doi.org/10.15479/AT:ISTA:8620">https://doi.org/10.15479/AT:ISTA:8620</a>
  chicago: Morandell, Jasmin. “Illuminating the Role of Cul3 in Autism Spectrum Disorder
    Pathogenesis.” Institute of Science and Technology Austria, 2020. <a href="https://doi.org/10.15479/AT:ISTA:8620">https://doi.org/10.15479/AT:ISTA:8620</a>.
  ieee: J. Morandell, “Illuminating the role of Cul3 in autism spectrum disorder pathogenesis,”
    Institute of Science and Technology Austria, 2020.
  ista: Morandell J. 2020. Illuminating the role of Cul3 in autism spectrum disorder
    pathogenesis. Institute of Science and Technology Austria.
  mla: Morandell, Jasmin. <i>Illuminating the Role of Cul3 in Autism Spectrum Disorder
    Pathogenesis</i>. Institute of Science and Technology Austria, 2020, doi:<a href="https://doi.org/10.15479/AT:ISTA:8620">10.15479/AT:ISTA:8620</a>.
  short: J. Morandell, Illuminating the Role of Cul3 in Autism Spectrum Disorder Pathogenesis,
    Institute of Science and Technology Austria, 2020.
date_created: 2020-10-07T14:53:13Z
date_published: 2020-10-12T00:00:00Z
date_updated: 2024-09-10T12:04:25Z
day: '12'
ddc:
- '610'
degree_awarded: PhD
department:
- _id: GaNo
doi: 10.15479/AT:ISTA:8620
file:
- access_level: open_access
  checksum: 7ee83e42de3e5ce2fedb44dff472f75f
  content_type: application/pdf
  creator: jmorande
  date_created: 2020-10-07T14:41:49Z
  date_updated: 2021-10-16T22:30:04Z
  embargo: 2021-10-15
  file_id: '8621'
  file_name: Jasmin_Morandell_Thesis-2020_final.pdf
  file_size: 16155786
  relation: main_file
- access_level: closed
  checksum: 5e0464af453734210ce7aab7b4a92e3a
  content_type: application/x-zip-compressed
  creator: jmorande
  date_created: 2020-10-07T14:45:07Z
  date_updated: 2021-10-16T22:30:04Z
  embargo_to: open_access
  file_id: '8622'
  file_name: Jasmin_Morandell_Thesis-2020_final.zip
  file_size: 24344152
  relation: source_file
file_date_updated: 2021-10-16T22:30:04Z
has_accepted_license: '1'
language:
- iso: eng
month: '10'
oa: 1
oa_version: Published Version
page: '138'
project:
- _id: 2548AE96-B435-11E9-9278-68D0E5697425
  call_identifier: FWF
  grant_number: W1232-B24
  name: Molecular Drug Targets
- _id: 05A0D778-7A3F-11EA-A408-12923DDC885E
  grant_number: F07807
  name: Neural stem cells in autism and epilepsy
publication_identifier:
  issn:
  - 2663-337X
publication_status: published
publisher: Institute of Science and Technology Austria
related_material:
  record:
  - id: '7800'
    relation: part_of_dissertation
    status: public
  - id: '8131'
    relation: part_of_dissertation
    status: public
status: public
supervisor:
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
title: Illuminating the role of Cul3 in autism spectrum disorder pathogenesis
type: dissertation
user_id: c635000d-4b10-11ee-a964-aac5a93f6ac1
year: '2020'
...
---
_id: '7149'
abstract:
- lang: eng
  text: In recent years, many genes have been associated with chromatinopathies classified
    as “Cornelia de Lange Syndrome‐like.” It is known that the phenotype of these
    patients becomes less recognizable, overlapping to features characteristic of
    other syndromes caused by genetic variants affecting different regulators of chromatin
    structure and function. Therefore, Cornelia de Lange syndrome diagnosis might
    be arduous due to the seldom discordance between unexpected molecular diagnosis
    and clinical evaluation. Here, we review the molecular features of Cornelia de
    Lange syndrome, supporting the hypothesis that “CdLS‐like syndromes” are part
    of a larger “rare disease family” sharing multiple clinical features and common
    disrupted molecular pathways.
acknowledgement: ' Dipartimento DiSS, Università degli Studi di Milano, Grant/Award
  Number: Linea 2; Fondazione Cariplo, Grant/Award Number: 2015-0783; German Federal
  Ministry of Education and Research (BMBF), Grant/Award Number: CHROMATIN-Net; Medical
  Faculty of the University of Lübeck, Grant/Award Number: J09-2017; Nickel & Co S.p.A.;
  Università degli Studi di Milano, Grant/Award Numbers: Molecular & Translational
  Medicine PhD Scholarship, Translational Medicine PhD Scholarship'
article_processing_charge: No
article_type: review
author:
- first_name: Laura
  full_name: Avagliano, Laura
  last_name: Avagliano
- first_name: Ilaria
  full_name: Parenti, Ilaria
  id: D93538B0-5B71-11E9-AC62-02EBE5697425
  last_name: Parenti
- first_name: Paolo
  full_name: Grazioli, Paolo
  last_name: Grazioli
- first_name: Elisabetta
  full_name: Di Fede, Elisabetta
  last_name: Di Fede
- first_name: Chiara
  full_name: Parodi, Chiara
  last_name: Parodi
- first_name: Milena
  full_name: Mariani, Milena
  last_name: Mariani
- first_name: Frank J.
  full_name: Kaiser, Frank J.
  last_name: Kaiser
- first_name: Angelo
  full_name: Selicorni, Angelo
  last_name: Selicorni
- first_name: Cristina
  full_name: Gervasini, Cristina
  last_name: Gervasini
- first_name: Valentina
  full_name: Massa, Valentina
  last_name: Massa
citation:
  ama: 'Avagliano L, Parenti I, Grazioli P, et al. Chromatinopathies: A focus on Cornelia
    de Lange syndrome. <i>Clinical Genetics</i>. 2020;97(1):3-11. doi:<a href="https://doi.org/10.1111/cge.13674">10.1111/cge.13674</a>'
  apa: 'Avagliano, L., Parenti, I., Grazioli, P., Di Fede, E., Parodi, C., Mariani,
    M., … Massa, V. (2020). Chromatinopathies: A focus on Cornelia de Lange syndrome.
    <i>Clinical Genetics</i>. Wiley. <a href="https://doi.org/10.1111/cge.13674">https://doi.org/10.1111/cge.13674</a>'
  chicago: 'Avagliano, Laura, Ilaria Parenti, Paolo Grazioli, Elisabetta Di Fede,
    Chiara Parodi, Milena Mariani, Frank J. Kaiser, Angelo Selicorni, Cristina Gervasini,
    and Valentina Massa. “Chromatinopathies: A Focus on Cornelia de Lange Syndrome.”
    <i>Clinical Genetics</i>. Wiley, 2020. <a href="https://doi.org/10.1111/cge.13674">https://doi.org/10.1111/cge.13674</a>.'
  ieee: 'L. Avagliano <i>et al.</i>, “Chromatinopathies: A focus on Cornelia de Lange
    syndrome,” <i>Clinical Genetics</i>, vol. 97, no. 1. Wiley, pp. 3–11, 2020.'
  ista: 'Avagliano L, Parenti I, Grazioli P, Di Fede E, Parodi C, Mariani M, Kaiser
    FJ, Selicorni A, Gervasini C, Massa V. 2020. Chromatinopathies: A focus on Cornelia
    de Lange syndrome. Clinical Genetics. 97(1), 3–11.'
  mla: 'Avagliano, Laura, et al. “Chromatinopathies: A Focus on Cornelia de Lange
    Syndrome.” <i>Clinical Genetics</i>, vol. 97, no. 1, Wiley, 2020, pp. 3–11, doi:<a
    href="https://doi.org/10.1111/cge.13674">10.1111/cge.13674</a>.'
  short: L. Avagliano, I. Parenti, P. Grazioli, E. Di Fede, C. Parodi, M. Mariani,
    F.J. Kaiser, A. Selicorni, C. Gervasini, V. Massa, Clinical Genetics 97 (2020)
    3–11.
date_created: 2019-12-04T16:10:59Z
date_published: 2020-01-01T00:00:00Z
date_updated: 2023-08-17T14:06:20Z
day: '01'
department:
- _id: GaNo
doi: 10.1111/cge.13674
external_id:
  isi:
  - '000562561800001'
  pmid:
  - '31721174'
intvolume: '        97'
isi: 1
issue: '1'
language:
- iso: eng
month: '01'
oa_version: None
page: 3-11
pmid: 1
publication: Clinical Genetics
publication_identifier:
  eissn:
  - 1399-0004
  issn:
  - 0009-9163
publication_status: published
publisher: Wiley
quality_controlled: '1'
scopus_import: '1'
status: public
title: 'Chromatinopathies: A focus on Cornelia de Lange syndrome'
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 97
year: '2020'
...
---
_id: '7488'
abstract:
- lang: eng
  text: Characteristic or classic phenotype of Cornelia de Lange syndrome (CdLS) is
    associated with a recognisable facial pattern. However, the heterogeneity in causal
    genes and the presence of overlapping syndromes have made it increasingly difficult
    to diagnose only by clinical features. DeepGestalt technology, and its app Face2Gene,
    is having a growing impact on the diagnosis and management of genetic diseases
    by analysing the features of affected individuals. Here, we performed a phenotypic
    study on a cohort of 49 individuals harbouring causative variants in known CdLS
    genes in order to evaluate Face2Gene utility and sensitivity in the clinical diagnosis
    of CdLS. Based on the profile images of patients, a diagnosis of CdLS was within
    the top five predicted syndromes for 97.9% of our cases and even listed as first
    prediction for 83.7%. The age of patients did not seem to affect the prediction
    accuracy, whereas our results indicate a correlation between the clinical score
    and affected genes. Furthermore, each gene presents a different pattern recognition
    that may be used to develop new neural networks with the goal of separating different
    genetic subtypes in CdLS. Overall, we conclude that computer-assisted image analysis
    based on deep learning could support the clinical diagnosis of CdLS.
article_number: '1042'
article_processing_charge: No
article_type: original
author:
- first_name: Ana
  full_name: Latorre-Pellicer, Ana
  last_name: Latorre-Pellicer
- first_name: Ángela
  full_name: Ascaso, Ángela
  last_name: Ascaso
- first_name: Laura
  full_name: Trujillano, Laura
  last_name: Trujillano
- first_name: Marta
  full_name: Gil-Salvador, Marta
  last_name: Gil-Salvador
- first_name: Maria
  full_name: Arnedo, Maria
  last_name: Arnedo
- first_name: Cristina
  full_name: Lucia-Campos, Cristina
  last_name: Lucia-Campos
- first_name: Rebeca
  full_name: Antoñanzas-Pérez, Rebeca
  last_name: Antoñanzas-Pérez
- first_name: Iñigo
  full_name: Marcos-Alcalde, Iñigo
  last_name: Marcos-Alcalde
- first_name: Ilaria
  full_name: Parenti, Ilaria
  id: D93538B0-5B71-11E9-AC62-02EBE5697425
  last_name: Parenti
- first_name: Gloria
  full_name: Bueno-Lozano, Gloria
  last_name: Bueno-Lozano
- first_name: Antonio
  full_name: Musio, Antonio
  last_name: Musio
- first_name: Beatriz
  full_name: Puisac, Beatriz
  last_name: Puisac
- first_name: Frank J.
  full_name: Kaiser, Frank J.
  last_name: Kaiser
- first_name: Feliciano J.
  full_name: Ramos, Feliciano J.
  last_name: Ramos
- first_name: Paulino
  full_name: Gómez-Puertas, Paulino
  last_name: Gómez-Puertas
- first_name: Juan
  full_name: Pié, Juan
  last_name: Pié
citation:
  ama: Latorre-Pellicer A, Ascaso Á, Trujillano L, et al. Evaluating Face2Gene as
    a tool to identify Cornelia de Lange syndrome by facial phenotypes. <i>International
    Journal of Molecular Sciences</i>. 2020;21(3). doi:<a href="https://doi.org/10.3390/ijms21031042">10.3390/ijms21031042</a>
  apa: Latorre-Pellicer, A., Ascaso, Á., Trujillano, L., Gil-Salvador, M., Arnedo,
    M., Lucia-Campos, C., … Pié, J. (2020). Evaluating Face2Gene as a tool to identify
    Cornelia de Lange syndrome by facial phenotypes. <i>International Journal of Molecular
    Sciences</i>. MDPI. <a href="https://doi.org/10.3390/ijms21031042">https://doi.org/10.3390/ijms21031042</a>
  chicago: Latorre-Pellicer, Ana, Ángela Ascaso, Laura Trujillano, Marta Gil-Salvador,
    Maria Arnedo, Cristina Lucia-Campos, Rebeca Antoñanzas-Pérez, et al. “Evaluating
    Face2Gene as a Tool to Identify Cornelia de Lange Syndrome by Facial Phenotypes.”
    <i>International Journal of Molecular Sciences</i>. MDPI, 2020. <a href="https://doi.org/10.3390/ijms21031042">https://doi.org/10.3390/ijms21031042</a>.
  ieee: A. Latorre-Pellicer <i>et al.</i>, “Evaluating Face2Gene as a tool to identify
    Cornelia de Lange syndrome by facial phenotypes,” <i>International Journal of
    Molecular Sciences</i>, vol. 21, no. 3. MDPI, 2020.
  ista: Latorre-Pellicer A, Ascaso Á, Trujillano L, Gil-Salvador M, Arnedo M, Lucia-Campos
    C, Antoñanzas-Pérez R, Marcos-Alcalde I, Parenti I, Bueno-Lozano G, Musio A, Puisac
    B, Kaiser FJ, Ramos FJ, Gómez-Puertas P, Pié J. 2020. Evaluating Face2Gene as
    a tool to identify Cornelia de Lange syndrome by facial phenotypes. International
    Journal of Molecular Sciences. 21(3), 1042.
  mla: Latorre-Pellicer, Ana, et al. “Evaluating Face2Gene as a Tool to Identify Cornelia
    de Lange Syndrome by Facial Phenotypes.” <i>International Journal of Molecular
    Sciences</i>, vol. 21, no. 3, 1042, MDPI, 2020, doi:<a href="https://doi.org/10.3390/ijms21031042">10.3390/ijms21031042</a>.
  short: A. Latorre-Pellicer, Á. Ascaso, L. Trujillano, M. Gil-Salvador, M. Arnedo,
    C. Lucia-Campos, R. Antoñanzas-Pérez, I. Marcos-Alcalde, I. Parenti, G. Bueno-Lozano,
    A. Musio, B. Puisac, F.J. Kaiser, F.J. Ramos, P. Gómez-Puertas, J. Pié, International
    Journal of Molecular Sciences 21 (2020).
date_created: 2020-02-16T23:00:49Z
date_published: 2020-02-04T00:00:00Z
date_updated: 2023-08-18T06:35:41Z
day: '04'
ddc:
- '570'
department:
- _id: GaNo
doi: 10.3390/ijms21031042
external_id:
  isi:
  - '000522551606028'
file:
- access_level: open_access
  checksum: 0e6658c4fe329d55d4d9bef01c5b15d0
  content_type: application/pdf
  creator: dernst
  date_created: 2020-02-18T07:49:22Z
  date_updated: 2020-07-14T12:47:59Z
  file_id: '7496'
  file_name: 2020_IntMolecSciences_Latorre.pdf
  file_size: 4271234
  relation: main_file
file_date_updated: 2020-07-14T12:47:59Z
has_accepted_license: '1'
intvolume: '        21'
isi: 1
issue: '3'
language:
- iso: eng
month: '02'
oa: 1
oa_version: Published Version
publication: International Journal of Molecular Sciences
publication_identifier:
  eissn:
  - '14220067'
  issn:
  - '16616596'
publication_status: published
publisher: MDPI
quality_controlled: '1'
scopus_import: '1'
status: public
title: Evaluating Face2Gene as a tool to identify Cornelia de Lange syndrome by facial
  phenotypes
tmp:
  image: /images/cc_by.png
  legal_code_url: https://creativecommons.org/licenses/by/4.0/legalcode
  name: Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)
  short: CC BY (4.0)
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 21
year: '2020'
...
---
_id: '7586'
abstract:
- lang: eng
  text: CLC chloride/proton exchangers may support acidification of endolysosomes
    and raise their luminal Cl− concentration. Disruption of endosomal ClC‐3 causes
    severe neurodegeneration. To assess the importance of ClC‐3 Cl−/H+ exchange, we
    now generate Clcn3unc/unc mice in which ClC‐3 is converted into a Cl− channel.
    Unlike Clcn3−/− mice, Clcn3unc/unc mice appear normal owing to compensation by
    ClC‐4 with which ClC‐3 forms heteromers. ClC‐4 protein levels are strongly reduced
    in Clcn3−/−, but not in Clcn3unc/unc mice because ClC‐3unc binds and stabilizes
    ClC‐4 like wild‐type ClC‐3. Although mice lacking ClC‐4 appear healthy, its absence
    in Clcn3unc/unc/Clcn4−/− mice entails even stronger neurodegeneration than observed
    in Clcn3−/− mice. A fraction of ClC‐3 is found on synaptic vesicles, but miniature
    postsynaptic currents and synaptic vesicle acidification are not affected in Clcn3unc/unc
    or Clcn3−/− mice before neurodegeneration sets in. Both, Cl−/H+‐exchange activity
    and the stabilizing effect on ClC‐4, are central to the biological function of
    ClC‐3.
acknowledgement: "We thank T. Stauber and T. Breiderhoff for cloning expression constructs;
  K. Räbel, S. Hohensee, and C. Backhaus for technical assistance; R. Jahn (MPIbpc,
  Göttingen) for providing the equipment required for SV purification; and A\r\nWoehler
  (MDC, Berlin) for assistance with SV imaging. Supported, in part, by grants from
  the Deutsche Forschungsgemeinschaft (JE164/9-2, SFB740 TP C5, FOR 2625 (JE164/14-1),
  NeuroCure Cluster of Excellence), the European Research Council Advanced Grant CYTOVOLION
  (ERC 294435) and the Prix Louis-Jeantet de Médecine to TJJ, and Peter and Traudl
  Engelhorn fellowship to ZF."
article_number: e103358
article_processing_charge: No
article_type: original
author:
- first_name: Stefanie
  full_name: Weinert, Stefanie
  last_name: Weinert
- first_name: Niclas
  full_name: Gimber, Niclas
  last_name: Gimber
- first_name: Dorothea
  full_name: Deuschel, Dorothea
  last_name: Deuschel
- first_name: Till
  full_name: Stuhlmann, Till
  last_name: Stuhlmann
- first_name: Dmytro
  full_name: Puchkov, Dmytro
  last_name: Puchkov
- first_name: Zohreh
  full_name: Farsi, Zohreh
  last_name: Farsi
- first_name: Carmen F.
  full_name: Ludwig, Carmen F.
  last_name: Ludwig
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
- first_name: Karen I.
  full_name: López-Cayuqueo, Karen I.
  last_name: López-Cayuqueo
- first_name: Rosa
  full_name: Planells-Cases, Rosa
  last_name: Planells-Cases
- first_name: Thomas J.
  full_name: Jentsch, Thomas J.
  last_name: Jentsch
citation:
  ama: Weinert S, Gimber N, Deuschel D, et al. Uncoupling endosomal CLC chloride/proton
    exchange causes severe neurodegeneration. <i>EMBO Journal</i>. 2020;39. doi:<a
    href="https://doi.org/10.15252/embj.2019103358">10.15252/embj.2019103358</a>
  apa: Weinert, S., Gimber, N., Deuschel, D., Stuhlmann, T., Puchkov, D., Farsi, Z.,
    … Jentsch, T. J. (2020). Uncoupling endosomal CLC chloride/proton exchange causes
    severe neurodegeneration. <i>EMBO Journal</i>. EMBO Press. <a href="https://doi.org/10.15252/embj.2019103358">https://doi.org/10.15252/embj.2019103358</a>
  chicago: Weinert, Stefanie, Niclas Gimber, Dorothea Deuschel, Till Stuhlmann, Dmytro
    Puchkov, Zohreh Farsi, Carmen F. Ludwig, et al. “Uncoupling Endosomal CLC Chloride/Proton
    Exchange Causes Severe Neurodegeneration.” <i>EMBO Journal</i>. EMBO Press, 2020.
    <a href="https://doi.org/10.15252/embj.2019103358">https://doi.org/10.15252/embj.2019103358</a>.
  ieee: S. Weinert <i>et al.</i>, “Uncoupling endosomal CLC chloride/proton exchange
    causes severe neurodegeneration,” <i>EMBO Journal</i>, vol. 39. EMBO Press, 2020.
  ista: Weinert S, Gimber N, Deuschel D, Stuhlmann T, Puchkov D, Farsi Z, Ludwig CF,
    Novarino G, López-Cayuqueo KI, Planells-Cases R, Jentsch TJ. 2020. Uncoupling
    endosomal CLC chloride/proton exchange causes severe neurodegeneration. EMBO Journal.
    39, e103358.
  mla: Weinert, Stefanie, et al. “Uncoupling Endosomal CLC Chloride/Proton Exchange
    Causes Severe Neurodegeneration.” <i>EMBO Journal</i>, vol. 39, e103358, EMBO
    Press, 2020, doi:<a href="https://doi.org/10.15252/embj.2019103358">10.15252/embj.2019103358</a>.
  short: S. Weinert, N. Gimber, D. Deuschel, T. Stuhlmann, D. Puchkov, Z. Farsi, C.F.
    Ludwig, G. Novarino, K.I. López-Cayuqueo, R. Planells-Cases, T.J. Jentsch, EMBO
    Journal 39 (2020).
date_created: 2020-03-15T23:00:55Z
date_published: 2020-03-02T00:00:00Z
date_updated: 2023-08-18T07:07:36Z
day: '02'
ddc:
- '570'
department:
- _id: GaNo
doi: 10.15252/embj.2019103358
external_id:
  isi:
  - '000517335000001'
  pmid:
  - '32118314'
file:
- access_level: open_access
  checksum: 82750a7a93e3740decbce8474004111a
  content_type: application/pdf
  creator: dernst
  date_created: 2020-03-23T13:51:11Z
  date_updated: 2020-07-14T12:48:00Z
  file_id: '7615'
  file_name: 2020_EMBO_Weinert.pdf
  file_size: 12243278
  relation: main_file
file_date_updated: 2020-07-14T12:48:00Z
has_accepted_license: '1'
intvolume: '        39'
isi: 1
language:
- iso: eng
month: '03'
oa: 1
oa_version: Published Version
pmid: 1
publication: EMBO Journal
publication_identifier:
  eissn:
  - '14602075'
  issn:
  - '02614189'
publication_status: published
publisher: EMBO Press
quality_controlled: '1'
scopus_import: '1'
status: public
title: Uncoupling endosomal CLC chloride/proton exchange causes severe neurodegeneration
tmp:
  image: /images/cc_by_nc_nd.png
  legal_code_url: https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode
  name: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
    (CC BY-NC-ND 4.0)
  short: CC BY-NC-ND (4.0)
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 39
year: '2020'
...
---
_id: '6896'
abstract:
- lang: eng
  text: "Until recently, a great amount of brain studies have been conducted in human
    post mortem tissues, cell lines and model organisms. These researches provided
    useful insights regarding cell-cell interactions occurring in the brain. However,
    such approaches suffer from technical limitations and inaccurate modeling of the
    tissue 3D cytoarchitecture. Importantly, they might lack a human genetic background
    essential for disease modeling. With the development of protocols to generate
    human cerebral organoids, we are now closer to reproducing the early stages of
    human brain development in vitro. As a result, more relevant cell-cell interaction
    studies can be conducted.\r\n\r\nIn this review, we discuss the advantages of
    3D cultures over 2D in modulating brain cell-cell interactions during physiological
    and pathological development, as well as the progress made in developing organoids
    in which neurons, macroglia, microglia and vascularization are present. Finally,
    we debate the limitations of those models and possible future directions."
article_number: '146458'
article_processing_charge: No
article_type: original
author:
- first_name: Bárbara
  full_name: Oliveira, Bárbara
  id: 3B03AA1A-F248-11E8-B48F-1D18A9856A87
  last_name: Oliveira
- first_name: Aysan Çerağ
  full_name: Yahya, Aysan Çerağ
  id: 365A65F8-F248-11E8-B48F-1D18A9856A87
  last_name: Yahya
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: Oliveira B, Yahya AÇ, Novarino G. Modeling cell-cell interactions in the brain
    using cerebral organoids. <i>Brain Research</i>. 2019;1724. doi:<a href="https://doi.org/10.1016/j.brainres.2019.146458">10.1016/j.brainres.2019.146458</a>
  apa: Oliveira, B., Yahya, A. Ç., &#38; Novarino, G. (2019). Modeling cell-cell interactions
    in the brain using cerebral organoids. <i>Brain Research</i>. Elsevier. <a href="https://doi.org/10.1016/j.brainres.2019.146458">https://doi.org/10.1016/j.brainres.2019.146458</a>
  chicago: Oliveira, Bárbara, Aysan Çerağ Yahya, and Gaia Novarino. “Modeling Cell-Cell
    Interactions in the Brain Using Cerebral Organoids.” <i>Brain Research</i>. Elsevier,
    2019. <a href="https://doi.org/10.1016/j.brainres.2019.146458">https://doi.org/10.1016/j.brainres.2019.146458</a>.
  ieee: B. Oliveira, A. Ç. Yahya, and G. Novarino, “Modeling cell-cell interactions
    in the brain using cerebral organoids,” <i>Brain Research</i>, vol. 1724. Elsevier,
    2019.
  ista: Oliveira B, Yahya AÇ, Novarino G. 2019. Modeling cell-cell interactions in
    the brain using cerebral organoids. Brain Research. 1724, 146458.
  mla: Oliveira, Bárbara, et al. “Modeling Cell-Cell Interactions in the Brain Using
    Cerebral Organoids.” <i>Brain Research</i>, vol. 1724, 146458, Elsevier, 2019,
    doi:<a href="https://doi.org/10.1016/j.brainres.2019.146458">10.1016/j.brainres.2019.146458</a>.
  short: B. Oliveira, A.Ç. Yahya, G. Novarino, Brain Research 1724 (2019).
date_created: 2019-09-22T22:00:35Z
date_published: 2019-12-01T00:00:00Z
date_updated: 2023-08-30T06:19:49Z
day: '01'
department:
- _id: GaNo
doi: 10.1016/j.brainres.2019.146458
external_id:
  isi:
  - '000491646600033'
  pmid:
  - '31521639'
intvolume: '      1724'
isi: 1
language:
- iso: eng
month: '12'
oa_version: None
pmid: 1
publication: Brain Research
publication_identifier:
  eissn:
  - '18726240'
  issn:
  - '00068993'
publication_status: published
publisher: Elsevier
quality_controlled: '1'
scopus_import: '1'
status: public
title: Modeling cell-cell interactions in the brain using cerebral organoids
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 1724
year: '2019'
...
---
_id: '7414'
article_processing_charge: No
article_type: original
author:
- first_name: Lisa
  full_name: Knaus, Lisa
  id: 3B2ABCF4-F248-11E8-B48F-1D18A9856A87
  last_name: Knaus
- first_name: Dora-Clara
  full_name: Tarlungeanu, Dora-Clara
  id: 2ABCE612-F248-11E8-B48F-1D18A9856A87
  last_name: Tarlungeanu
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: Knaus L, Tarlungeanu D-C, Novarino G. S.16.03 A homozygous missense mutation
    in SLC7A5 leads to autism spectrum disorder and microcephaly. <i>European Neuropsychopharmacology</i>.
    2019;29(Supplement 6):S11. doi:<a href="https://doi.org/10.1016/j.euroneuro.2019.09.039">10.1016/j.euroneuro.2019.09.039</a>
  apa: Knaus, L., Tarlungeanu, D.-C., &#38; Novarino, G. (2019). S.16.03 A homozygous
    missense mutation in SLC7A5 leads to autism spectrum disorder and microcephaly.
    <i>European Neuropsychopharmacology</i>. Elsevier. <a href="https://doi.org/10.1016/j.euroneuro.2019.09.039">https://doi.org/10.1016/j.euroneuro.2019.09.039</a>
  chicago: Knaus, Lisa, Dora-Clara Tarlungeanu, and Gaia Novarino. “S.16.03 A Homozygous
    Missense Mutation in SLC7A5 Leads to Autism Spectrum Disorder and Microcephaly.”
    <i>European Neuropsychopharmacology</i>. Elsevier, 2019. <a href="https://doi.org/10.1016/j.euroneuro.2019.09.039">https://doi.org/10.1016/j.euroneuro.2019.09.039</a>.
  ieee: L. Knaus, D.-C. Tarlungeanu, and G. Novarino, “S.16.03 A homozygous missense
    mutation in SLC7A5 leads to autism spectrum disorder and microcephaly,” <i>European
    Neuropsychopharmacology</i>, vol. 29, no. Supplement 6. Elsevier, p. S11, 2019.
  ista: Knaus L, Tarlungeanu D-C, Novarino G. 2019. S.16.03 A homozygous missense
    mutation in SLC7A5 leads to autism spectrum disorder and microcephaly. European
    Neuropsychopharmacology. 29(Supplement 6), S11.
  mla: Knaus, Lisa, et al. “S.16.03 A Homozygous Missense Mutation in SLC7A5 Leads
    to Autism Spectrum Disorder and Microcephaly.” <i>European Neuropsychopharmacology</i>,
    vol. 29, no. Supplement 6, Elsevier, 2019, p. S11, doi:<a href="https://doi.org/10.1016/j.euroneuro.2019.09.039">10.1016/j.euroneuro.2019.09.039</a>.
  short: L. Knaus, D.-C. Tarlungeanu, G. Novarino, European Neuropsychopharmacology
    29 (2019) S11.
date_created: 2020-01-30T10:06:15Z
date_published: 2019-12-13T00:00:00Z
date_updated: 2023-09-07T14:55:23Z
day: '13'
department:
- _id: GaNo
doi: 10.1016/j.euroneuro.2019.09.039
external_id:
  isi:
  - '000502657500020'
intvolume: '        29'
isi: 1
issue: Supplement 6
language:
- iso: eng
month: '12'
oa_version: None
page: S11
publication: European Neuropsychopharmacology
publication_identifier:
  issn:
  - 0924-977X
publication_status: published
publisher: Elsevier
quality_controlled: '1'
status: public
title: S.16.03 A homozygous missense mutation in SLC7A5 leads to autism spectrum disorder
  and microcephaly
type: journal_article
user_id: c635000d-4b10-11ee-a964-aac5a93f6ac1
volume: 29
year: '2019'
...
---
_id: '7415'
article_processing_charge: No
article_type: original
author:
- first_name: Jasmin
  full_name: Morandell, Jasmin
  id: 4739D480-F248-11E8-B48F-1D18A9856A87
  last_name: Morandell
- first_name: Armel
  full_name: Nicolas, Armel
  id: 2A103192-F248-11E8-B48F-1D18A9856A87
  last_name: Nicolas
- first_name: Lena A
  full_name: Schwarz, Lena A
  id: 29A8453C-F248-11E8-B48F-1D18A9856A87
  last_name: Schwarz
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: Morandell J, Nicolas A, Schwarz LA, Novarino G. S.16.05 Illuminating the role
    of the e3 ubiquitin ligase cullin3 in brain development and autism. <i>European
    Neuropsychopharmacology</i>. 2019;29(Supplement 6):S11-S12. doi:<a href="https://doi.org/10.1016/j.euroneuro.2019.09.040">10.1016/j.euroneuro.2019.09.040</a>
  apa: Morandell, J., Nicolas, A., Schwarz, L. A., &#38; Novarino, G. (2019). S.16.05
    Illuminating the role of the e3 ubiquitin ligase cullin3 in brain development
    and autism. <i>European Neuropsychopharmacology</i>. Elsevier. <a href="https://doi.org/10.1016/j.euroneuro.2019.09.040">https://doi.org/10.1016/j.euroneuro.2019.09.040</a>
  chicago: Morandell, Jasmin, Armel Nicolas, Lena A Schwarz, and Gaia Novarino. “S.16.05
    Illuminating the Role of the E3 Ubiquitin Ligase Cullin3 in Brain Development
    and Autism.” <i>European Neuropsychopharmacology</i>. Elsevier, 2019. <a href="https://doi.org/10.1016/j.euroneuro.2019.09.040">https://doi.org/10.1016/j.euroneuro.2019.09.040</a>.
  ieee: J. Morandell, A. Nicolas, L. A. Schwarz, and G. Novarino, “S.16.05 Illuminating
    the role of the e3 ubiquitin ligase cullin3 in brain development and autism,”
    <i>European Neuropsychopharmacology</i>, vol. 29, no. Supplement 6. Elsevier,
    pp. S11–S12, 2019.
  ista: Morandell J, Nicolas A, Schwarz LA, Novarino G. 2019. S.16.05 Illuminating
    the role of the e3 ubiquitin ligase cullin3 in brain development and autism. European
    Neuropsychopharmacology. 29(Supplement 6), S11–S12.
  mla: Morandell, Jasmin, et al. “S.16.05 Illuminating the Role of the E3 Ubiquitin
    Ligase Cullin3 in Brain Development and Autism.” <i>European Neuropsychopharmacology</i>,
    vol. 29, no. Supplement 6, Elsevier, 2019, pp. S11–12, doi:<a href="https://doi.org/10.1016/j.euroneuro.2019.09.040">10.1016/j.euroneuro.2019.09.040</a>.
  short: J. Morandell, A. Nicolas, L.A. Schwarz, G. Novarino, European Neuropsychopharmacology
    29 (2019) S11–S12.
date_created: 2020-01-30T10:07:41Z
date_published: 2019-12-13T00:00:00Z
date_updated: 2023-09-07T14:56:17Z
day: '13'
department:
- _id: GaNo
- _id: LifeSc
doi: 10.1016/j.euroneuro.2019.09.040
external_id:
  isi:
  - '000502657500021'
intvolume: '        29'
isi: 1
issue: Supplement 6
language:
- iso: eng
month: '12'
oa_version: None
page: S11-S12
publication: European Neuropsychopharmacology
publication_identifier:
  issn:
  - 0924-977X
publication_status: published
publisher: Elsevier
quality_controlled: '1'
status: public
title: S.16.05 Illuminating the role of the e3 ubiquitin ligase cullin3 in brain development
  and autism
type: journal_article
user_id: c635000d-4b10-11ee-a964-aac5a93f6ac1
volume: 29
year: '2019'
...
---
_id: '6074'
abstract:
- lang: eng
  text: "This dataset contains the supplementary data for the research paper \"Haploinsufficiency
    of the intellectual disability gene SETD5 disturbs developmental gene expression
    and cognition\".\r\n\r\nThe contained files have the following content:\r\n'Supplementary
    Figures.pdf'\r\n\tAdditional figures (as referenced in the paper).\r\n'Supplementary
    Table 1. Statistics.xlsx'\r\n\tDetails on statistical tests performed in the paper.\r\n'Supplementary
    Table 2. Differentially expressed gene analysis.xlsx'\r\n\tResults for the differential
    gene expression analysis for embryonic (E9.5; analysis with edgeR) and in vitro
    (ESCs, EBs, NPCs; analysis with DESeq2) samples.\r\n'Supplementary Table 3. Gene
    Ontology (GO) term enrichment analysis.xlsx'\r\n\tResults for the GO term enrichment
    analysis for differentially expressed genes in embryonic (GO E9.5) and in vitro
    (GO ESC, GO EBs, GO NPCs) samples. Differentially expressed genes for in vitro
    samples were split into upregulated and downregulated genes (up/down) and the
    analysis was performed on each subset (e.g. GO ESC up / GO ESC down).\r\n'Supplementary
    Table 4. Differentially expressed gene analysis for CFC samples.xlsx'\r\n\tResults
    for the differential gene expression analysis for samples from adult mice before
    (HC - Homecage) and 1h and 3h after contextual fear conditioning (1h and 3h, respectively).
    Each sheet shows the results for a different comparison. Sheets 1-3 show results
    for comparisons between timepoints for wild type (WT) samples only and sheets
    4-6 for the same comparisons in mutant (Het) samples. Sheets 7-9 show results
    for comparisons between genotypes at each time point and sheet 10 contains the
    results for the analysis of differential expression trajectories between wild
    type and mutant.\r\n'Supplementary Table 5. Cluster identification.xlsx'\r\n\tResults
    for k-means clustering of genes by expression. Sheet 1 shows clustering of just
    the genes with significantly different expression trajectories between genotypes.
    Sheet 2 shows clustering of all genes that are significantly differentially expressed
    in any of the comparisons (includes also genes with same trajectories).\r\n'Supplementary
    Table 6. GO term cluster analysis.xlsx'\r\n\tResults for the GO term enrichment
    analysis and EWCE analysis for enrichment of cell type specific genes for each
    cluster identified by clustering genes with different expression trajectories
    (see Table S5, sheet 1).\r\n'Supplementary Table 7. Setd5 mass spectrometry results.xlsx'\r\n\tResults
    showing proteins interacting with Setd5 as identified by mass spectrometry. Sheet
    1 shows protein protein interaction data generated from these results (combined
    with data from the STRING database. Sheet 2 shows the results of the statistical
    analysis with limma.\r\n'Supplementary Table 8. PolII ChIP-seq analysis.xlsx'\r\n\tResults
    for the Chip-Seq analysis for binding of RNA polymerase II (PolII). Sheet 1 shows
    results for differential binding of PolII at the transcription start site (TSS)
    between genotypes and sheets 2+3 show the corresponding GO enrichment analysis
    for these differentially bound genes. Sheet 4 shows RNAseq counts for genes with
    increased binding of PolII at the TSS."
article_processing_charge: No
author:
- first_name: Christoph
  full_name: Dotter, Christoph
  id: 4C66542E-F248-11E8-B48F-1D18A9856A87
  last_name: Dotter
  orcid: 0000-0002-9033-9096
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: Dotter C, Novarino G. Supplementary data for the research paper “Haploinsufficiency
    of the intellectual disability gene SETD5 disturbs developmental gene expression
    and cognition.” 2019. doi:<a href="https://doi.org/10.15479/AT:ISTA:6074">10.15479/AT:ISTA:6074</a>
  apa: Dotter, C., &#38; Novarino, G. (2019). Supplementary data for the research
    paper “Haploinsufficiency of the intellectual disability gene SETD5 disturbs developmental
    gene expression and cognition.” Institute of Science and Technology Austria. <a
    href="https://doi.org/10.15479/AT:ISTA:6074">https://doi.org/10.15479/AT:ISTA:6074</a>
  chicago: Dotter, Christoph, and Gaia Novarino. “Supplementary Data for the Research
    Paper ‘Haploinsufficiency of the Intellectual Disability Gene SETD5 Disturbs Developmental
    Gene Expression and Cognition.’” Institute of Science and Technology Austria,
    2019. <a href="https://doi.org/10.15479/AT:ISTA:6074">https://doi.org/10.15479/AT:ISTA:6074</a>.
  ieee: C. Dotter and G. Novarino, “Supplementary data for the research paper ‘Haploinsufficiency
    of the intellectual disability gene SETD5 disturbs developmental gene expression
    and cognition.’” Institute of Science and Technology Austria, 2019.
  ista: Dotter C, Novarino G. 2019. Supplementary data for the research paper ‘Haploinsufficiency
    of the intellectual disability gene SETD5 disturbs developmental gene expression
    and cognition’, Institute of Science and Technology Austria, <a href="https://doi.org/10.15479/AT:ISTA:6074">10.15479/AT:ISTA:6074</a>.
  mla: Dotter, Christoph, and Gaia Novarino. <i>Supplementary Data for the Research
    Paper “Haploinsufficiency of the Intellectual Disability Gene SETD5 Disturbs Developmental
    Gene Expression and Cognition.”</i> Institute of Science and Technology Austria,
    2019, doi:<a href="https://doi.org/10.15479/AT:ISTA:6074">10.15479/AT:ISTA:6074</a>.
  short: C. Dotter, G. Novarino, (2019).
date_created: 2019-03-07T13:32:35Z
date_published: 2019-01-09T00:00:00Z
date_updated: 2024-02-21T13:41:01Z
day: '09'
ddc:
- '570'
department:
- _id: GaNo
doi: 10.15479/AT:ISTA:6074
file:
- access_level: open_access
  checksum: bc1b285edca9e98a2c63d153c79bb75b
  content_type: application/zip
  creator: dernst
  date_created: 2019-03-07T13:37:19Z
  date_updated: 2020-07-14T12:47:18Z
  file_id: '6084'
  file_name: Setd5_paper.zip
  file_size: 33202743
  relation: supplementary_material
file_date_updated: 2020-07-14T12:47:18Z
has_accepted_license: '1'
month: '01'
oa: 1
oa_version: Published Version
publisher: Institute of Science and Technology Austria
related_material:
  record:
  - id: '3'
    relation: research_paper
    status: public
status: public
title: Supplementary data for the research paper "Haploinsufficiency of the intellectual
  disability gene SETD5 disturbs developmental gene expression and cognition"
type: research_data
user_id: 2DF688A6-F248-11E8-B48F-1D18A9856A87
year: '2019'
...
---
_id: '6088'
abstract:
- lang: eng
  text: P-Glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) are two
    efflux transporters at the blood–brain barrier (BBB), which effectively restrict
    brain distribution of diverse drugs, such as tyrosine kinase inhibitors. There
    is a crucial need for pharmacological ABCB1 and ABCG2 inhibition protocols for
    a more effective treatment of brain diseases. In the present study, seven marketed
    drugs (osimertinib, erlotinib, nilotinib, imatinib, lapatinib, pazopanib, and
    cyclosporine A) and one nonmarketed drug (tariquidar), with known in vitro ABCB1/ABCG2
    inhibitory properties, were screened for their inhibitory potency at the BBB in
    vivo. Positron emission tomography (PET) using the model ABCB1/ABCG2 substrate
    [11C]erlotinib was performed in mice. Tested inhibitors were administered as i.v.
    bolus injections at 30 min before the start of the PET scan, followed by a continuous
    i.v. infusion for the duration of the PET scan. Five of the tested drugs increased
    total distribution volume of [11C]erlotinib in the brain (VT,brain) compared to
    vehicle-treated animals (tariquidar, + 69%; erlotinib, + 19% and +23% for the
    21.5 mg/kg and the 43 mg/kg dose, respectively; imatinib, + 22%; lapatinib, +
    25%; and cyclosporine A, + 49%). For all drugs, increases in [11C]erlotinib brain
    distribution were lower than in Abcb1a/b(−/−)Abcg2(−/−) mice (+149%), which suggested
    that only partial ABCB1/ABCG2 inhibition was reached at the mouse BBB. The plasma
    concentrations of the tested drugs at the time of the PET scan were higher than
    clinically achievable plasma concentrations. Some of the tested drugs led to significant
    increases in blood radioactivity concentrations measured at the end of the PET
    scan (erlotinib, + 103% and +113% for the 21.5 mg/kg and the 43 mg/kg dose, respectively;
    imatinib, + 125%; and cyclosporine A, + 101%), which was most likely caused by
    decreased hepatobiliary excretion of radioactivity. Taken together, our data suggest
    that some marketed tyrosine kinase inhibitors may be repurposed to inhibit ABCB1
    and ABCG2 at the BBB. From a clinical perspective, moderate increases in brain
    delivery despite the administration of high i.v. doses as well as peripheral drug–drug
    interactions due to transporter inhibition in clearance organs question the translatability
    of this concept.
article_processing_charge: No
author:
- first_name: Alexander
  full_name: Traxl, Alexander
  last_name: Traxl
- first_name: Severin
  full_name: Mairinger, Severin
  last_name: Mairinger
- first_name: Thomas
  full_name: Filip, Thomas
  last_name: Filip
- first_name: Michael
  full_name: Sauberer, Michael
  last_name: Sauberer
- first_name: Johann
  full_name: Stanek, Johann
  last_name: Stanek
- first_name: Stefan
  full_name: Poschner, Stefan
  last_name: Poschner
- first_name: Walter
  full_name: Jäger, Walter
  last_name: Jäger
- first_name: Viktoria
  full_name: Zoufal, Viktoria
  last_name: Zoufal
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
- first_name: Nicolas
  full_name: Tournier, Nicolas
  last_name: Tournier
- first_name: Martin
  full_name: Bauer, Martin
  last_name: Bauer
- first_name: Thomas
  full_name: Wanek, Thomas
  last_name: Wanek
- first_name: Oliver
  full_name: Langer, Oliver
  last_name: Langer
citation:
  ama: Traxl A, Mairinger S, Filip T, et al. Inhibition of ABCB1 and ABCG2 at the
    mouse blood-brain barrier with marketed drugs to improve brain delivery of the
    model ABCB1/ABCG2 substrate [11C]erlotinib. <i>Molecular Pharmaceutics</i>. 2019;16(3):1282-1293.
    doi:<a href="https://doi.org/10.1021/acs.molpharmaceut.8b01217">10.1021/acs.molpharmaceut.8b01217</a>
  apa: Traxl, A., Mairinger, S., Filip, T., Sauberer, M., Stanek, J., Poschner, S.,
    … Langer, O. (2019). Inhibition of ABCB1 and ABCG2 at the mouse blood-brain barrier
    with marketed drugs to improve brain delivery of the model ABCB1/ABCG2 substrate
    [11C]erlotinib. <i>Molecular Pharmaceutics</i>. American Chemical Society. <a
    href="https://doi.org/10.1021/acs.molpharmaceut.8b01217">https://doi.org/10.1021/acs.molpharmaceut.8b01217</a>
  chicago: Traxl, Alexander, Severin Mairinger, Thomas Filip, Michael Sauberer, Johann
    Stanek, Stefan Poschner, Walter Jäger, et al. “Inhibition of ABCB1 and ABCG2 at
    the Mouse Blood-Brain Barrier with Marketed Drugs to Improve Brain Delivery of
    the Model ABCB1/ABCG2 Substrate [11C]Erlotinib.” <i>Molecular Pharmaceutics</i>.
    American Chemical Society, 2019. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b01217">https://doi.org/10.1021/acs.molpharmaceut.8b01217</a>.
  ieee: A. Traxl <i>et al.</i>, “Inhibition of ABCB1 and ABCG2 at the mouse blood-brain
    barrier with marketed drugs to improve brain delivery of the model ABCB1/ABCG2
    substrate [11C]erlotinib,” <i>Molecular Pharmaceutics</i>, vol. 16, no. 3. American
    Chemical Society, pp. 1282–1293, 2019.
  ista: Traxl A, Mairinger S, Filip T, Sauberer M, Stanek J, Poschner S, Jäger W,
    Zoufal V, Novarino G, Tournier N, Bauer M, Wanek T, Langer O. 2019. Inhibition
    of ABCB1 and ABCG2 at the mouse blood-brain barrier with marketed drugs to improve
    brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib. Molecular Pharmaceutics.
    16(3), 1282–1293.
  mla: Traxl, Alexander, et al. “Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain
    Barrier with Marketed Drugs to Improve Brain Delivery of the Model ABCB1/ABCG2
    Substrate [11C]Erlotinib.” <i>Molecular Pharmaceutics</i>, vol. 16, no. 3, American
    Chemical Society, 2019, pp. 1282–93, doi:<a href="https://doi.org/10.1021/acs.molpharmaceut.8b01217">10.1021/acs.molpharmaceut.8b01217</a>.
  short: A. Traxl, S. Mairinger, T. Filip, M. Sauberer, J. Stanek, S. Poschner, W.
    Jäger, V. Zoufal, G. Novarino, N. Tournier, M. Bauer, T. Wanek, O. Langer, Molecular
    Pharmaceutics 16 (2019) 1282–1293.
date_created: 2019-03-10T22:59:19Z
date_published: 2019-03-04T00:00:00Z
date_updated: 2023-08-25T08:02:51Z
day: '04'
department:
- _id: GaNo
doi: 10.1021/acs.molpharmaceut.8b01217
external_id:
  isi:
  - '000460600400031'
  pmid:
  - '30694684'
intvolume: '        16'
isi: 1
issue: '3'
language:
- iso: eng
month: '03'
oa_version: None
page: 1282-1293
pmid: 1
publication: Molecular Pharmaceutics
publication_status: published
publisher: American Chemical Society
quality_controlled: '1'
scopus_import: '1'
status: public
title: Inhibition of ABCB1 and ABCG2 at the mouse blood-brain barrier with marketed
  drugs to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 16
year: '2019'
...
---
_id: '6470'
abstract:
- lang: eng
  text: 'Investigating neuronal activity using genetically encoded Ca2+ indicators
    in behaving animals is hampered by inaccuracies in spike inference from fluorescent
    tracers. Here we combine two‐photon [Ca2+] imaging with cell‐attached recordings,
    followed by post hoc determination of the expression level of GCaMP6f, to explore
    how it affects the amplitude, kinetics and temporal summation of somatic [Ca2+]
    transients in mouse hippocampal pyramidal cells (PCs). The amplitude of unitary
    [Ca2+] transients (evoked by a single action potential) negatively correlates
    with GCaMP6f expression, but displays large variability even among PCs with similarly
    low expression levels. The summation of fluorescence signals is frequency‐dependent,
    supralinear and also shows remarkable cell‐to‐cell variability. We performed experimental
    data‐based simulations and found that spike inference error rates using MLspike
    depend strongly on unitary peak amplitudes and GCaMP6f expression levels. We provide
    simple methods for estimating the unitary [Ca2+] transients in individual weakly
    GCaMP6f‐expressing PCs, with which we achieve spike inference error rates of ∼5%. '
article_processing_charge: No
article_type: original
author:
- first_name: Tímea
  full_name: Éltes, Tímea
  last_name: Éltes
- first_name: Miklos
  full_name: Szoboszlay, Miklos
  last_name: Szoboszlay
- first_name: Margit Katalin
  full_name: Szigeti, Margit Katalin
  id: 44F4BDC0-F248-11E8-B48F-1D18A9856A87
  last_name: Szigeti
  orcid: 0000-0001-9500-8758
- first_name: Zoltan
  full_name: Nusser, Zoltan
  last_name: Nusser
citation:
  ama: Éltes T, Szoboszlay M, Szigeti MK, Nusser Z. Improved spike inference accuracy
    by estimating the peak amplitude of unitary [Ca2+] transients in weakly GCaMP6f-expressing
    hippocampal pyramidal cells. <i>Journal of Physiology</i>. 2019;597(11):2925–2947.
    doi:<a href="https://doi.org/10.1113/JP277681">10.1113/JP277681</a>
  apa: Éltes, T., Szoboszlay, M., Szigeti, M. K., &#38; Nusser, Z. (2019). Improved
    spike inference accuracy by estimating the peak amplitude of unitary [Ca2+] transients
    in weakly GCaMP6f-expressing hippocampal pyramidal cells. <i>Journal of Physiology</i>.
    Wiley. <a href="https://doi.org/10.1113/JP277681">https://doi.org/10.1113/JP277681</a>
  chicago: Éltes, Tímea, Miklos Szoboszlay, Margit Katalin Szigeti, and Zoltan Nusser.
    “Improved Spike Inference Accuracy by Estimating the Peak Amplitude of Unitary
    [Ca2+] Transients in Weakly GCaMP6f-Expressing Hippocampal Pyramidal Cells.” <i>Journal
    of Physiology</i>. Wiley, 2019. <a href="https://doi.org/10.1113/JP277681">https://doi.org/10.1113/JP277681</a>.
  ieee: T. Éltes, M. Szoboszlay, M. K. Szigeti, and Z. Nusser, “Improved spike inference
    accuracy by estimating the peak amplitude of unitary [Ca2+] transients in weakly
    GCaMP6f-expressing hippocampal pyramidal cells,” <i>Journal of Physiology</i>,
    vol. 597, no. 11. Wiley, pp. 2925–2947, 2019.
  ista: Éltes T, Szoboszlay M, Szigeti MK, Nusser Z. 2019. Improved spike inference
    accuracy by estimating the peak amplitude of unitary [Ca2+] transients in weakly
    GCaMP6f-expressing hippocampal pyramidal cells. Journal of Physiology. 597(11),
    2925–2947.
  mla: Éltes, Tímea, et al. “Improved Spike Inference Accuracy by Estimating the Peak
    Amplitude of Unitary [Ca2+] Transients in Weakly GCaMP6f-Expressing Hippocampal
    Pyramidal Cells.” <i>Journal of Physiology</i>, vol. 597, no. 11, Wiley, 2019,
    pp. 2925–2947, doi:<a href="https://doi.org/10.1113/JP277681">10.1113/JP277681</a>.
  short: T. Éltes, M. Szoboszlay, M.K. Szigeti, Z. Nusser, Journal of Physiology 597
    (2019) 2925–2947.
date_created: 2019-05-19T21:59:17Z
date_published: 2019-06-01T00:00:00Z
date_updated: 2023-08-25T10:34:15Z
day: '01'
department:
- _id: GaNo
doi: 10.1113/JP277681
external_id:
  isi:
  - '000470780400013'
  pmid:
  - '31006863'
intvolume: '       597'
isi: 1
issue: '11'
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://doi.org/10.1113/JP277681
month: '06'
oa: 1
oa_version: Published Version
page: 2925–2947
pmid: 1
publication: Journal of Physiology
publication_identifier:
  eissn:
  - '14697793'
  issn:
  - '00223751'
publication_status: published
publisher: Wiley
quality_controlled: '1'
scopus_import: '1'
status: public
title: Improved spike inference accuracy by estimating the peak amplitude of unitary
  [Ca2+] transients in weakly GCaMP6f-expressing hippocampal pyramidal cells
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 597
year: '2019'
...
---
_id: '105'
abstract:
- lang: eng
  text: 'Clinical Utility Gene Card. 1. Name of Disease (Synonyms): Pontocerebellar
    hypoplasia type 9 (PCH9) and spastic paraplegia-63 (SPG63). 2. OMIM# of the Disease:
    615809 and 615686. 3. Name of the Analysed Genes or DNA/Chromosome Segments: AMPD2
    at 1p13.3. 4. OMIM# of the Gene(s): 102771.'
acknowledgement: 'This work was supported by EuroGentest2 (Unit 2: “Genetic testing
  as part of health care”), a Coordination Action under FP7 (Grant Agreement Number
  261469) and the European Society of Human Genetics. We acknowledge the participation
  of the patients and their families in these studies, as well as the generous financial
  support of the Lefroy and Handbury families. APLM was supported by an Australian
  Postgraduate Award. PJL is supported by an NHMRC Career Development Fellowship (GNT1032364).
  RJL is supported by a Melbourne Children’s Clinician Scientist Fellowship.'
article_processing_charge: No
article_type: original
author:
- first_name: Ashley
  full_name: Marsh, Ashley
  last_name: Marsh
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
- first_name: Paul
  full_name: Lockhart, Paul
  last_name: Lockhart
- first_name: Richard
  full_name: Leventer, Richard
  last_name: Leventer
citation:
  ama: Marsh A, Novarino G, Lockhart P, Leventer R. CUGC for pontocerebellar hypoplasia
    type 9 and spastic paraplegia-63. <i>European Journal of Human Genetics</i>. 2019;27:161-166.
    doi:<a href="https://doi.org/10.1038/s41431-018-0231-2">10.1038/s41431-018-0231-2</a>
  apa: Marsh, A., Novarino, G., Lockhart, P., &#38; Leventer, R. (2019). CUGC for
    pontocerebellar hypoplasia type 9 and spastic paraplegia-63. <i>European Journal
    of Human Genetics</i>. Springer Nature. <a href="https://doi.org/10.1038/s41431-018-0231-2">https://doi.org/10.1038/s41431-018-0231-2</a>
  chicago: Marsh, Ashley, Gaia Novarino, Paul Lockhart, and Richard Leventer. “CUGC
    for Pontocerebellar Hypoplasia Type 9 and Spastic Paraplegia-63.” <i>European
    Journal of Human Genetics</i>. Springer Nature, 2019. <a href="https://doi.org/10.1038/s41431-018-0231-2">https://doi.org/10.1038/s41431-018-0231-2</a>.
  ieee: A. Marsh, G. Novarino, P. Lockhart, and R. Leventer, “CUGC for pontocerebellar
    hypoplasia type 9 and spastic paraplegia-63,” <i>European Journal of Human Genetics</i>,
    vol. 27. Springer Nature, pp. 161–166, 2019.
  ista: Marsh A, Novarino G, Lockhart P, Leventer R. 2019. CUGC for pontocerebellar
    hypoplasia type 9 and spastic paraplegia-63. European Journal of Human Genetics.
    27, 161–166.
  mla: Marsh, Ashley, et al. “CUGC for Pontocerebellar Hypoplasia Type 9 and Spastic
    Paraplegia-63.” <i>European Journal of Human Genetics</i>, vol. 27, Springer Nature,
    2019, pp. 161–66, doi:<a href="https://doi.org/10.1038/s41431-018-0231-2">10.1038/s41431-018-0231-2</a>.
  short: A. Marsh, G. Novarino, P. Lockhart, R. Leventer, European Journal of Human
    Genetics 27 (2019) 161–166.
date_created: 2018-12-11T11:44:39Z
date_published: 2019-01-01T00:00:00Z
date_updated: 2023-08-24T14:28:24Z
day: '01'
department:
- _id: GaNo
doi: 10.1038/s41431-018-0231-2
external_id:
  isi:
  - '000454111500019'
  pmid:
  - '30089829'
intvolume: '        27'
isi: 1
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://doi.org/10.1038/s41431-018-0231-2
month: '01'
oa: 1
oa_version: Published Version
page: 161-166
pmid: 1
publication: European Journal of Human Genetics
publication_status: published
publisher: Springer Nature
publist_id: '7949'
quality_controlled: '1'
scopus_import: '1'
status: public
title: CUGC for pontocerebellar hypoplasia type 9 and spastic paraplegia-63
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 27
year: '2019'
...
---
_id: '3'
abstract:
- lang: eng
  text: SETD5 gene mutations have been identified as a frequent cause of idiopathic
    intellectual disability. Here we show that Setd5-haploinsufficient mice present
    developmental defects such as abnormal brain-to-body weight ratios and neural
    crest defect-associated phenotypes. Furthermore, Setd5-mutant mice show impairments
    in cognitive tasks, enhanced long-term potentiation, delayed ontogenetic profile
    of ultrasonic vocalization, and behavioral inflexibility. Behavioral issues are
    accompanied by abnormal expression of postsynaptic density proteins previously
    associated with cognition. Our data additionally indicate that Setd5 regulates
    RNA polymerase II dynamics and gene transcription via its interaction with the
    Hdac3 and Paf1 complexes, findings potentially explaining the gene expression
    defects observed in Setd5-haploinsufficient mice. Our results emphasize the decisive
    role of Setd5 in a biological pathway found to be disrupted in humans with intellectual
    disability and autism spectrum disorder.
acknowledged_ssus:
- _id: M-Shop
- _id: PreCl
acknowledgement: This work was supported by the Simons Foundation Autism Research
  Initiative (grant 401299) to G.N. and the DFG (SPP1738 grant NO 1249) to K.-M.N.
article_processing_charge: No
article_type: original
author:
- first_name: Elena
  full_name: Deliu, Elena
  id: 37A40D7E-F248-11E8-B48F-1D18A9856A87
  last_name: Deliu
  orcid: 0000-0002-7370-5293
- first_name: Niccoló
  full_name: Arecco, Niccoló
  last_name: Arecco
- first_name: Jasmin
  full_name: Morandell, Jasmin
  id: 4739D480-F248-11E8-B48F-1D18A9856A87
  last_name: Morandell
- first_name: Christoph
  full_name: Dotter, Christoph
  id: 4C66542E-F248-11E8-B48F-1D18A9856A87
  last_name: Dotter
  orcid: 0000-0002-9033-9096
- first_name: Ximena
  full_name: Contreras, Ximena
  id: 475990FE-F248-11E8-B48F-1D18A9856A87
  last_name: Contreras
- first_name: Charles
  full_name: Girardot, Charles
  last_name: Girardot
- first_name: Eva
  full_name: Käsper, Eva
  last_name: Käsper
- first_name: Alena
  full_name: Kozlova, Alena
  id: C50A9596-02D0-11E9-976E-E38CFE5CBC1D
  last_name: Kozlova
- first_name: Kasumi
  full_name: Kishi, Kasumi
  id: 3065DFC4-F248-11E8-B48F-1D18A9856A87
  last_name: Kishi
- first_name: Ilaria
  full_name: Chiaradia, Ilaria
  id: B6467F20-02D0-11E9-BDA5-E960C241894A
  last_name: Chiaradia
  orcid: 0000-0002-9529-4464
- first_name: Kyung
  full_name: Noh, Kyung
  last_name: Noh
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: Deliu E, Arecco N, Morandell J, et al. Haploinsufficiency of the intellectual
    disability gene SETD5 disturbs developmental gene expression and cognition. <i>Nature
    Neuroscience</i>. 2018;21(12):1717-1727. doi:<a href="https://doi.org/10.1038/s41593-018-0266-2">10.1038/s41593-018-0266-2</a>
  apa: Deliu, E., Arecco, N., Morandell, J., Dotter, C., Contreras, X., Girardot,
    C., … Novarino, G. (2018). Haploinsufficiency of the intellectual disability gene
    SETD5 disturbs developmental gene expression and cognition. <i>Nature Neuroscience</i>.
    Nature Publishing Group. <a href="https://doi.org/10.1038/s41593-018-0266-2">https://doi.org/10.1038/s41593-018-0266-2</a>
  chicago: Deliu, Elena, Niccoló Arecco, Jasmin Morandell, Christoph Dotter, Ximena
    Contreras, Charles Girardot, Eva Käsper, et al. “Haploinsufficiency of the Intellectual
    Disability Gene SETD5 Disturbs Developmental Gene Expression and Cognition.” <i>Nature
    Neuroscience</i>. Nature Publishing Group, 2018. <a href="https://doi.org/10.1038/s41593-018-0266-2">https://doi.org/10.1038/s41593-018-0266-2</a>.
  ieee: E. Deliu <i>et al.</i>, “Haploinsufficiency of the intellectual disability
    gene SETD5 disturbs developmental gene expression and cognition,” <i>Nature Neuroscience</i>,
    vol. 21, no. 12. Nature Publishing Group, pp. 1717–1727, 2018.
  ista: Deliu E, Arecco N, Morandell J, Dotter C, Contreras X, Girardot C, Käsper
    E, Kozlova A, Kishi K, Chiaradia I, Noh K, Novarino G. 2018. Haploinsufficiency
    of the intellectual disability gene SETD5 disturbs developmental gene expression
    and cognition. Nature Neuroscience. 21(12), 1717–1727.
  mla: Deliu, Elena, et al. “Haploinsufficiency of the Intellectual Disability Gene
    SETD5 Disturbs Developmental Gene Expression and Cognition.” <i>Nature Neuroscience</i>,
    vol. 21, no. 12, Nature Publishing Group, 2018, pp. 1717–27, doi:<a href="https://doi.org/10.1038/s41593-018-0266-2">10.1038/s41593-018-0266-2</a>.
  short: E. Deliu, N. Arecco, J. Morandell, C. Dotter, X. Contreras, C. Girardot,
    E. Käsper, A. Kozlova, K. Kishi, I. Chiaradia, K. Noh, G. Novarino, Nature Neuroscience
    21 (2018) 1717–1727.
date_created: 2018-12-11T11:44:05Z
date_published: 2018-11-19T00:00:00Z
date_updated: 2024-03-25T23:30:25Z
day: '19'
ddc:
- '570'
department:
- _id: GaNo
- _id: EdHa
doi: 10.1038/s41593-018-0266-2
external_id:
  isi:
  - '000451324700010'
file:
- access_level: open_access
  checksum: 60abd0f05b7cdc08a6b0ec460884084f
  content_type: application/pdf
  creator: dernst
  date_created: 2019-04-09T07:41:57Z
  date_updated: 2020-07-14T12:45:58Z
  file_id: '6255'
  file_name: 2017_NatureNeuroscience_Deliu.pdf
  file_size: 8167169
  relation: main_file
file_date_updated: 2020-07-14T12:45:58Z
has_accepted_license: '1'
intvolume: '        21'
isi: 1
issue: '12'
language:
- iso: eng
month: '11'
oa: 1
oa_version: Submitted Version
page: 1717 - 1727
project:
- _id: 254BA948-B435-11E9-9278-68D0E5697425
  grant_number: '401299'
  name: Probing development and reversibility of autism spectrum disorders
publication: Nature Neuroscience
publication_status: published
publisher: Nature Publishing Group
publist_id: '8054'
pubrep_id: '1071'
quality_controlled: '1'
related_material:
  link:
  - description: News on IST Homepage
    relation: press_release
    url: https://ist.ac.at/en/news/mutation-that-causes-autism-and-intellectual-disability-makes-brain-less-flexible/
  record:
  - id: '6074'
    relation: popular_science
    status: public
  - id: '12364'
    relation: dissertation_contains
    status: public
scopus_import: '1'
status: public
title: Haploinsufficiency of the intellectual disability gene SETD5 disturbs developmental
  gene expression and cognition
type: journal_article
user_id: c635000d-4b10-11ee-a964-aac5a93f6ac1
volume: 21
year: '2018'
...
---
_id: '691'
abstract:
- lang: eng
  text: "Background: Transport protein particle (TRAPP) is a multisubunit complex
    that regulates membrane trafficking through the Golgi apparatus. The clinical
    phenotype associated with mutations in various TRAPP subunits has allowed elucidation
    of their functions in specific tissues. The role of some subunits in human disease,
    however, has not been fully established, and their functions remain uncertain.\r\n\r\nObjective:
    We aimed to expand the range of neurodevelopmental disorders associated with mutations
    in TRAPP subunits by exome sequencing of consanguineous families.\r\n\r\nMethods:
    Linkage and homozygosity mapping and candidate gene analysis were used to identify
    homozygous mutations in families. Patient fibroblasts were used to study splicing
    defect and zebrafish to model the disease.\r\n\r\nResults: We identified six individuals
    from three unrelated families with a founder homozygous splice mutation in TRAPPC6B,
    encoding a core subunit of the complex TRAPP I. Patients manifested a neurodevelopmental
    disorder characterised by microcephaly, epilepsy and autistic features, and showed
    splicing defect. Zebrafish trappc6b morphants replicated the human phenotype,
    displaying decreased head size and neuronal hyperexcitability, leading to a lower
    seizure threshold.\r\n\r\nConclusion: This study provides clinical and functional
    evidence of the role of TRAPPC6B in brain development and function."
article_processing_charge: No
article_type: original
author:
- first_name: Isaac
  full_name: Marin Valencia, Isaac
  last_name: Marin Valencia
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
- first_name: Anide
  full_name: Johansen, Anide
  last_name: Johansen
- first_name: Başak
  full_name: Rosti, Başak
  last_name: Rosti
- first_name: Mahmoud
  full_name: Issa, Mahmoud
  last_name: Issa
- first_name: Damir
  full_name: Musaev, Damir
  last_name: Musaev
- first_name: Gifty
  full_name: Bhat, Gifty
  last_name: Bhat
- first_name: Eric
  full_name: Scott, Eric
  last_name: Scott
- first_name: Jennifer
  full_name: Silhavy, Jennifer
  last_name: Silhavy
- first_name: Valentina
  full_name: Stanley, Valentina
  last_name: Stanley
- first_name: Rasim
  full_name: Rosti, Rasim
  last_name: Rosti
- first_name: Jeremy
  full_name: Gleeson, Jeremy
  last_name: Gleeson
- first_name: Farhad
  full_name: Imam, Farhad
  last_name: Imam
- first_name: Maha
  full_name: Zaki, Maha
  last_name: Zaki
- first_name: Joseph
  full_name: Gleeson, Joseph
  last_name: Gleeson
citation:
  ama: Marin Valencia I, Novarino G, Johansen A, et al. A homozygous founder mutation
    in TRAPPC6B associates with a neurodevelopmental disorder characterised by microcephaly
    epilepsy and autistic features. <i>Journal of Medical Genetics</i>. 2018;55(1):48-54.
    doi:<a href="https://doi.org/10.1136/jmedgenet-2017-104627">10.1136/jmedgenet-2017-104627</a>
  apa: Marin Valencia, I., Novarino, G., Johansen, A., Rosti, B., Issa, M., Musaev,
    D., … Gleeson, J. (2018). A homozygous founder mutation in TRAPPC6B associates
    with a neurodevelopmental disorder characterised by microcephaly epilepsy and
    autistic features. <i>Journal of Medical Genetics</i>. BMJ Publishing Group. <a
    href="https://doi.org/10.1136/jmedgenet-2017-104627">https://doi.org/10.1136/jmedgenet-2017-104627</a>
  chicago: Marin Valencia, Isaac, Gaia Novarino, Anide Johansen, Başak Rosti, Mahmoud
    Issa, Damir Musaev, Gifty Bhat, et al. “A Homozygous Founder Mutation in TRAPPC6B
    Associates with a Neurodevelopmental Disorder Characterised by Microcephaly Epilepsy
    and Autistic Features.” <i>Journal of Medical Genetics</i>. BMJ Publishing Group,
    2018. <a href="https://doi.org/10.1136/jmedgenet-2017-104627">https://doi.org/10.1136/jmedgenet-2017-104627</a>.
  ieee: I. Marin Valencia <i>et al.</i>, “A homozygous founder mutation in TRAPPC6B
    associates with a neurodevelopmental disorder characterised by microcephaly epilepsy
    and autistic features,” <i>Journal of Medical Genetics</i>, vol. 55, no. 1. BMJ
    Publishing Group, pp. 48–54, 2018.
  ista: Marin Valencia I, Novarino G, Johansen A, Rosti B, Issa M, Musaev D, Bhat
    G, Scott E, Silhavy J, Stanley V, Rosti R, Gleeson J, Imam F, Zaki M, Gleeson
    J. 2018. A homozygous founder mutation in TRAPPC6B associates with a neurodevelopmental
    disorder characterised by microcephaly epilepsy and autistic features. Journal
    of Medical Genetics. 55(1), 48–54.
  mla: Marin Valencia, Isaac, et al. “A Homozygous Founder Mutation in TRAPPC6B Associates
    with a Neurodevelopmental Disorder Characterised by Microcephaly Epilepsy and
    Autistic Features.” <i>Journal of Medical Genetics</i>, vol. 55, no. 1, BMJ Publishing
    Group, 2018, pp. 48–54, doi:<a href="https://doi.org/10.1136/jmedgenet-2017-104627">10.1136/jmedgenet-2017-104627</a>.
  short: I. Marin Valencia, G. Novarino, A. Johansen, B. Rosti, M. Issa, D. Musaev,
    G. Bhat, E. Scott, J. Silhavy, V. Stanley, R. Rosti, J. Gleeson, F. Imam, M. Zaki,
    J. Gleeson, Journal of Medical Genetics 55 (2018) 48–54.
date_created: 2018-12-11T11:47:57Z
date_published: 2018-01-01T00:00:00Z
date_updated: 2023-10-16T09:55:43Z
day: '01'
department:
- _id: GaNo
doi: 10.1136/jmedgenet-2017-104627
external_id:
  isi:
  - '000418199800007'
  pmid:
  - '28626029'
intvolume: '        55'
isi: 1
issue: '1'
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056005/
month: '01'
oa: 1
oa_version: Submitted Version
page: 48 - 54
pmid: 1
project:
- _id: 254BA948-B435-11E9-9278-68D0E5697425
  grant_number: '401299'
  name: Probing development and reversibility of autism spectrum disorders
publication: Journal of Medical Genetics
publication_identifier:
  issn:
  - 0022-2593
publication_status: published
publisher: BMJ Publishing Group
publist_id: '7016'
quality_controlled: '1'
scopus_import: '1'
status: public
title: A homozygous founder mutation in TRAPPC6B associates with a neurodevelopmental
  disorder characterised by microcephaly epilepsy and autistic features
type: journal_article
user_id: 2DF688A6-F248-11E8-B48F-1D18A9856A87
volume: 55
year: '2018'
...
---
_id: '456'
abstract:
- lang: eng
  text: 'Inhibition of the endoplasmic reticulum stress pathway may hold the key to
    Zika virus-associated microcephaly treatment. '
article_number: eaar7514
author:
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
citation:
  ama: 'Novarino G. Zika-associated microcephaly: Reduce the stress and race for the
    treatment. <i>Science Translational Medicine</i>. 2018;10(423). doi:<a href="https://doi.org/10.1126/scitranslmed.aar7514">10.1126/scitranslmed.aar7514</a>'
  apa: 'Novarino, G. (2018). Zika-associated microcephaly: Reduce the stress and race
    for the treatment. <i>Science Translational Medicine</i>. American Association
    for the Advancement of Science. <a href="https://doi.org/10.1126/scitranslmed.aar7514">https://doi.org/10.1126/scitranslmed.aar7514</a>'
  chicago: 'Novarino, Gaia. “Zika-Associated Microcephaly: Reduce the Stress and Race
    for the Treatment.” <i>Science Translational Medicine</i>. American Association
    for the Advancement of Science, 2018. <a href="https://doi.org/10.1126/scitranslmed.aar7514">https://doi.org/10.1126/scitranslmed.aar7514</a>.'
  ieee: 'G. Novarino, “Zika-associated microcephaly: Reduce the stress and race for
    the treatment,” <i>Science Translational Medicine</i>, vol. 10, no. 423. American
    Association for the Advancement of Science, 2018.'
  ista: 'Novarino G. 2018. Zika-associated microcephaly: Reduce the stress and race
    for the treatment. Science Translational Medicine. 10(423), eaar7514.'
  mla: 'Novarino, Gaia. “Zika-Associated Microcephaly: Reduce the Stress and Race
    for the Treatment.” <i>Science Translational Medicine</i>, vol. 10, no. 423, eaar7514,
    American Association for the Advancement of Science, 2018, doi:<a href="https://doi.org/10.1126/scitranslmed.aar7514">10.1126/scitranslmed.aar7514</a>.'
  short: G. Novarino, Science Translational Medicine 10 (2018).
date_created: 2018-12-11T11:46:34Z
date_published: 2018-01-10T00:00:00Z
date_updated: 2021-01-12T07:59:42Z
day: '10'
department:
- _id: GaNo
doi: 10.1126/scitranslmed.aar7514
intvolume: '        10'
issue: '423'
language:
- iso: eng
month: '01'
oa_version: None
publication: Science Translational Medicine
publication_status: published
publisher: American Association for the Advancement of Science
publist_id: '7365'
quality_controlled: '1'
scopus_import: 1
status: public
title: 'Zika-associated microcephaly: Reduce the stress and race for the treatment'
type: journal_article
user_id: 4435EBFC-F248-11E8-B48F-1D18A9856A87
volume: 10
year: '2018'
...
